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TC1/BDAT S, S’-bis(?,??-dimethylacetic acid) trithiocarbonate 
TC2  Dibenzyl Trithiocarbonate 
TDT  1,3,5-Benzenetricarbodithioic acid / 1,3,5-tris(phenylmethyl) ester 
TEOS  Tetraethyl orthosilicate 
TGA  Thermogravimetric analysis 
UCST  Upper critical solution temperature 
VP  1-Vinyl-2-pyrrolidinone 
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6BAbstract 
This research has three parts. Two parts deal with novel nanoparticle assemblies for drug 
delivery, and are described in Part A, while the third part looks at properties of fish scales, 
an abundant and little-used waste resource, that can be modified to have value in medical 
and other areas.  
Part A describes fundamental research into the affects of block sequence of amphiphilic 
block copolymers prepared from on a new and versatile class of monomers, 
oligo(ethylene glycol) methyl ether acrylate (OEGA) and the more hydrophobic 
di(ethylene glycol) methyl ether methacrylate (DEGMA). Polymers from these 
monomers are biologically safe and give polymers with thermoresponsive properties that 
can be manipulated over a broader temperature range than the more researched N-
isopropylacrylamide polymers. Using RAFT polymerization and different Chain Transfer 
Agents (CTAs) amphiphilic block copolymers were prepared to study the effect of block 
sequence (hydrophilic OEGA and more hydrophobic DEGMA) on their thermo-
responsive properties. Pairing hydrophilic chain ends to a hydrophobic DEGMA block 
and hydrophobic chain ends to hydrophilic blocks (“mis-matched polarity”) significantly 
affected thermoresponsive properties for linear and star diblock copolymers, but little 
affected symmetric triblock copolymers. Specifically matching polarity in diblock 
copolymers yielded nanoparticles with higher cloud points (CP), narrow temperature 
ranges for coil collapse above CP, and smaller hydrodynamic diameter than mis-matched 
polarity. Using this knowledge two linear OEGA/DEGMA diblock copolymers were 
prepared with thiol end groups and assembled into hybrid nanoparticles with a gold 
nanoparticle core (GNP-polymer hybrids). This design was made using the hypothesis 
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that a hybrid polymer drug carrier with a high CP (50-60 ˚C) and a diblock structure 
could be designed with low levels of drug release below 37 ˚C (body temperature) 
allowing the drug carrier to reach a target (tumor) site with minimal drug loss and 
accompanying side effects, to healthy tissue. Once at a tumor site safe wavelengths of 
light could heat the gold core and polymer domain to above the CP releasing the bulk of 
the drug where it is needed. The results were promising but suggested additional 
modification of the copolymer is required to further reduce release low temperature drug 
release. The second half of Part A addressed multi-drug controlled release from tissue 
scaffolds prepared from “nanoparticle fibers”. Tissue scaffolding for cell regeneration 
requires the ability to both physically support cells and promote their growth. This may 
require a drug “cocktail” of low or high molecular weight drugs to be released at different 
rates depending on the therapeutic levels needed for each drug. This work succeeded in 
producing a novel, flexible, and robust system of assembled fibers of nanoparticles that 
could independently control the release of multiple drugs.  
Fish scale is an abundant and growing waste resource, with supplies far exceeding current 
uses, which have focused on harvesting the components of scales (hydroxyapatite and 
collagen) and ignored the scale itself. No studies have looked at the chemical 
modification of the intact scales, but such modifications may make scales suitable and 
even desirable additives into polymers for new composites with useful applications. Part 
B of this research investigated chemical modification of fish scales, characterized the 
changes to the upper biomineral layer and inner collagen layer, and the effects of these 
modifications on nanomechanical properties and moisture uptake. We described some 
possible uses for modified scales. 
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7BChapter 1 Introduction 
This dissertation has two major divisions. The first major division addresses two novel 
drug delivery systems design, and is described in Chapters 3, 4 and 5. The second major 
division is a fundamental study of the chemical modification and nano-mechanical 
analysis of fish scale, an abundant waste resource, and is described in Chapter 6.  
Chapter 3 describes a fundamental study of the affect of end group polarity and block 
sequence on the thermoresponse properties of novel amphiphilic block copolymers from 
a new class of ethylene glycol-containing (meth)acrylates. Polymers from these 
monomers have recently become of interest because of their  broad temperature range 
over which their cloud points (CPs) can be manipulated. Their block copolymers were 
investigated here as possible vehicles to address a a major challenge in the the area of 
drug delivery, which is to reduce the quantity of drug, particularly toxic drugs like 
chemo-therapy, that escape from nanoparticles when they are not at their target site. 
Diblock star copolymers and linear di- and triblock copolymers of hydrophilic 
oligo(ethylene glycol) methyl ether acrylate (OEGA) and more hydrophobic di(ethylene 
glycol) methyl ether methacrylate (DEGMA) monomers were prepared by RAFT 
polymerization with Chain Transfer Agents (CTAs) providing the end groups. The affect 
of matching or mis-matching chain end polarity and block sequence was studied on the 
hydrodynamic diameter, cloud point, and temperature range of the chain collapse on 
linear di- and triblock copolymers and star diblock polymers. The affects of matching or 
mis-matching chain end polarity were significant with linear diblock copolymers but 
more complex with triblock and star copolymers. This study allowed us to determine that 
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amphiphilic diblock copolymers of hydrophilic OEGA and more hydrophobic DEGMA 
with “matched” chain end polarity gave copolymers with higher CP, smaller 
hydrodynamic diameter, and narrower transition window than “mis-matching” polarity.  
The results from this study were used to design and test a gold nanoparticle(GNP)-
polymer hybrid as a novel “high-efficiency” thermoresponsive drug delivery carrier, as 
described in Chapter 4. Typically thermo-responsive drug-delivery polymers are selected 
with CPs near the temperature of the human body (37 ˚C), which means drug begins 
being released immediately when introduced into the body, whether or not it is at the 
target site. The rationale behind this design was that GNPs can absorb a bio-safe 
wavelegth of light and convert it to heat, thereby heating the GNPs local environment. 
When the temperature exceeds the polymer’s cloud point, the drug is released. We 
prepared and studied two amphiphilic “matched” diblock copolymers with CPs between 
50-60 ˚C whose end groups were selected so that the chain end bonded to the 
hydrophobic (drug carrier) block was thiol (T) to bond to the gold core, while the polar 
chain end was a –CO2H (C) which could ultimately be bonded to a targeting ligand. The 
two polymers were: T-D50O50-C (CP = 51.5 ºC) and T-D40O60-C (CP =59.8 ºC) and their 
GNP hybrids. The thero-responsive properties, composition, and end groups were 
verified by UV-vis hydrodynamic diameter, IR spectra, NMR spectra, drug loading 
(ibuprofen), and drug release were determined. The drug release profiles were measured 
at 4 different temperatures to understand how the thermoresponsive properties affect the 
releasing rate and efficiency. At 0.5 h time point, the release percent was from 16.7% to 
39.7% correspondence 20 ºC to 60 ºC, and it increased to 57.0% ~ 94.8% at 24 h. 
Although the low temperature drug release was still considered too high, the results were 
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promising, and showed that a larger hydrophobic core reduces early drug loss. Further 
studies are needed to improve polymer design for further reductions in early drug release. 
A novel multi-drug release tissue scaffold was studied in Chapter 5 to address another 
remaining challenge in drug delivery, i.e. the ability for a single scaffold device to 
simultaneously contain and independently control the release of multiple drugs, so each 
drug can be released and maintained at a therapeutic but non-toxic level. This work 
builds on the prior research from our group (Dr. Xiaochu Ding), who first synthesized 
and functionalized drug-containing nanoparticles with peptides and self-assembled these 
into continuous nanoparticle fibers and three-dimensional (3D) scaffolds. Ideally each 
drug is loaded into a “custom” nanoparticle composition the releases that drug at a 
suitable rate. The number and placement of these nanoparticles can be controlled by 
controlling the number of each nanoparticle and its assembly sequence. The novelty of 
this work was preparing and proving control over assembly sequence with three different 
model drug-containing nanoparticles, and quantifying the independent release of each 
drug from the scaffold. This type of nanoparticle scaffold combines the advantages of 
peptide self-assembly and the versatility of polymeric nanoparticle controlled release 
systems for tissue engineering. 
The second part of the dissertation was focus on a new biomaterial: fish scale. Fish scales 
are an abundant yet underutilized waste resource, with supplies far exceeding current 
uses. Current use for scales separate the main components for individual use, which 
sacrifices the properties inherently built into the scale through its hierarchical structure. 
Most research studies also focus on scale components, though recent research has studied 
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hierarchical scale designs. No prior studies have looked at the chemical modification of 
the scales themselves. Here, we used some basic chemical modifications of intact scales, 
and sought to preferentially degrade or enhance one of the two scale domains. The 
chemical, nanomechanical, and moisture uptake changes in the scale domains were tested 
to highlight pathways to potential property enhancements to suggest new applications for 
fish scale waste, and may benefit from the existing hierarchical scale design. The results 
from this research show that different domains can be preferentially (but not exclusively) 
modified and the modulus can be tuned over a broad range, however, all modifications 
resulted in increasing the moisture uptake of the scales compared to unmodified scales, 
indicating some structural damage to the scales despite modifications that increased 
modulus. 
  
5 
8BChapter 2 Introduction of RAFT Polymerization 
14B2.1 Introduction 
43B2.1.1 Controlled radical polymerization and RAFT polymerization 
Since the first report by Otsu and co-workers1 opened the door to Controlled Radical 
Polymerizations (CRP) it has become one of the most important polymer synthetic 
methods. This is because CRP allows previously difficult to prepare or even unobtainable 
polymers to prepare that have a desired microstructure such as diblock or triblock 
copolymers, controlled molecular weight, and narrow molecular weight distribution1. The 
most researched CRP methods are stable free radical mediated polymerization (SFRP), 
atom transfer radical polymerization (ATRP) and reversible addition fragmentation chain 
transfer (RAFT) polymerization. Each of these methods has certain advantages and 
disadvantages, but they all permit a greater degree of control over molecular weight 
(MW), monomer sequence, and polydispersity index (PDI) compared to non-controlled 
radical polymerization. The RAFT process appeared in the literature in the early 1970s1 
but in 1998 the use of dithioester chain transfer agents (CTA) was reported and spurred 
research into the RAFT polymerization method2. RAFT polymerization requires the use 
of both a traditional radical initiator as well as a CTA. Figure 2.1 shows two common 
types of CTA used to produce linear polymers (Z and R are function groups). 
 
108BFigure 2.1 Generic structures for a Dithioester and a Trithiocarbonate RAFT CTA. 
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RAFT affords the typical advantages often associated with CRP, i.e. control over end 
group3 4, MW5 and monomer sequence6. However, unlike other CRP methods, RAFT 
tolerates a very wide range of monomers, including functional monomers, such as acids 
and their salts, alcohols, and tertiary amines2 (Figure 2.2). However monomers bearing 
nucleophilic functional groups, such as primary or secondary amines, may cause 
unwanted decomposition of the RAFT moiety during polymerization4.  
 
109BFigure 2.2: Generic families of monomers suitable for RAFT polymerization 
 
RAFT polymerization also occurs under simple and environmentally friendly conditions, 
proceeding in water at room temperature without the need for protecting groups. Aqueous 
RAFT polymerization is well-suited for the synthesis of nano- and micro- scale self-
assembled polymers, which can be useful in electronics and biotechnology7 8.  
44B2.1.2 Mechanism of RAFT Polymerization and Formation of End 
groups 
The commonly accepted mechanism of RAFT polymerization is shown in Figure 2.3. 
Based on the equilibrium, end group control can be achieved through the choice of 
different kinds of CTAs3. Selecting a dithioester, such as that shown in Figure 2.1, gives a 
7 
CS2Z and R as the polymer chain end groups. Both of these groups also affect the final 
polymer properties, as well as aspects of the polymerization kinetics as shown in Figure 
2.3. Specifically, step two illustrates the initial equilibrium and re-initiation step, and in 
this step the Z group influences the addition rate. For example, Z groups with a 
conjugating structure will stabilize the radical on the carbon, slowing the fragmentation 
step. At the same time, the R group also plays a role in the fragmentation process by 
determining the strength of the S-R bond and the stability of the R• radical after 
fragmentation. That in turn affects the breaking and reforming of the S-R bond. If R• is 
unstable, the fragmentation process is slow because the high energy of activation favors 
maintaining the S–R bond. However, at the same time, because the R• is unstable, when 
it is formed it possesses a higher reaction rate between R• and the monomer. There is a 
balance between these two effects. In step three, the main equilibrium step, the R group 
has bonded to a monomer and functions as the unreactive end group of a growing 
polymer chain. Therefore, it is the Z group that plays an important role in the propagation 
(monomer addition) rate. By appropriate selection of the R and Z groups, the overall 
polymerization rate can be controlled. However, like most free radical reactions, the 
overall rate of a RAFT polymerization is controlled by multiple factors in the system, 
including steric and polar factors, solvent, reactant concentration and reaction 
temperature. 
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110BFigure 2.3: Schematic of RAFT polymerizations 
In RAFT polymerization, the two chain ends are designated as α- and ω- (Figure 2.4). 
Most chain ends arise from the Z (the ω- end) and R (the α- end) groups of the CTA. 
Consequently, the simplest way to achieve the desired chain ends is to employ a CTA 
with these end groups, but if that is not possible many CTA end groups are easily 
modified after polymer synthesis to give the desired chain ends. Both approaches are well 
represented in the literature.  
 
111BFigure 2.4: End groups of RAFT polymerizations 
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In the RAFT mechanism, the radical initiator (I• in Step 1 of Figure 2.4) and R group on 
the CTA give α- chain ends, while the ω- chain ends are from the CTA only. Various post 
polymerization modifications have been performed on both the α- and ω-end, but because 
all chains are likely to have an ω-end from the CTA, it is more common to remove or 
modify this end than the ?-end.4, 9 
15B2.2 CTA Synthesis 
45B2.2.1 Single functional CTAs of the ZCS2R type 
Four families of CTAs of the ZCS2R type have been reported, with the family being 
determined by the identity of the Z activating group. In the dithioesters Z = an aromatic 
or aliphatic group. In xanthates Z = –NR2, while in trithiocarbonates Z= –SR, and in 
dithiocarbamates Z = –OR. Every CTA includes a free-radical leaving group (R) and an 
activating group (Z). The structural effects of the Z group on reactivity were studied in 
2003.10 It was found that the N and O atoms in xanthates and dithiocarbamates can 
participate in resonance stabilization with the C=S double bond (Canonical forms: Figure 
2.5). These resonance structures affect the radical reactivity and therefore these CTAs 
give somewhat poor control of molecular weight10-11. Consequently, this introduction 
emphasizes recent studies with dithioesters and trithiocarbonates. 
 
112BFigure 2.5: Canonical forms of xanthates and dithiocarbamates 
 
10 
86B2.2.1.1 Dithioester CTAs: 
Dithioesters were reported in 1998 as RAFT CTAs2 and now are the most commonly 
used CTAs in RAFT. Dithioesters possess a simpler structure than trithiocarbonates, 
xanthates, and dithiocarbamates, and they are easy to synthesize. Dithioesters are 
commonly synthesized via Grignard reagents, phosphorous pentasulfide (P4S10), and 
Davy-R reagents, as illustrated below. 
105B2.2.1.1.1 Grignard route: 
 
113BFigure 2.6: General procedure to dithioester CTAs by Grignard route 
The Grignard route is simple and versatile and used to synthesize many thiocarbonyl 
compounds (Figure 2.6). Dithioesters are readily obtained by reaction of Grignard agents 
with halogenated compounds, so this method is often used for RAFT CTA synthesis 
(Figure 2.7, CTA1-CTA4). A dithiobenzoic acid intermediate can also be obtained by 
treating the PhCS2MgX intermediate with aqueous HCl 12. Dithiobenzoic acid is not 
stable at room temperature so it should be stored at or below –20 oC. Many reagents can 
be reacted with dithiobenzoic acid to access a great variety of different CTAs. In 
summary, the Grignard reaction is a valuable and versatile route to RAFT CTAs, but 
because Grignard reagents are sensitive to oxygen and water, the reaction conditions 
must be scrupulously controlled.  
11 
 
114BFigure 2.7: CTAs synthesized by a Grignard route 
106B2.2.1.1.2 Synthesis of CTAs from benzoic acid and P4S10 or Davy-R reagents:   
While the Grignard route is simple and versatile it does require careful control over the 
reaction conditions. CTA syntheses using P4S10 or Davy-R reagents require less stringent 
synthetic conditions. Figure 2.8 outlines four different routes to multifunctional 
dithioester CTAs, starting with reaction of benzoic acid and P4S10, giving a transient 
dithiobenzoic acid. This is converted to the desired CTAs in a single step13.  A great 
many thiols and alcohols have been reacted with carboxylic acids using P4S10 to give 
many different CTAs12 14. Three of the paths outlined in Figure 2.8 (paths A, B and C) 
proceed by a radical exchange process, while path D is a nucleophilic reaction. As stated, 
these routes occur in a single step and give high yields. 
12 
 
115BFigure 2.8: Synthesis of CTAs from P4S10 (Adapted from Angew. Chem. Int. Ed. 2003, 
42, 2869-2872) 
The Davy-R process, shown in Figure 2.9, is similar to the process using P4S10, and offers 
another route to synthesize dithioester CTAs.12  
 
116BFigure 2.9: Synthesis of CTAs using a Davy-R reagent. 
107B2.2.1.1.3 Other methods  
Radical exchange processes are a powerful, but often less efficient method to synthesize 
new CTAs. In this approach excess radicals (R’•) are used to replace the R group of an 
13 
existing dithioester moiety (-SR)10, 15.  This process is illustrated in Figure 2.10 and two 
examples of its use are given in Figure 2.11. Radical exchange processes can also be used 
in the synthesis of xanthates, as described elsewhere in 200616.  
 
117BFigure 2.10: Radical exchange process 
 
118BFigure 2.11: Examples of radical exchange  
87B2.2.1.2 Trithiocarbonate CTAs: 
Trithiocarbonates are also commonly used CTAs in RAFT polymerization.  A typical 
synthetic procedure is shown in Figure 2.12. 
 
119BFigure 2.12: Procedure to synthesize trithiocarbonate CTAs 
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120BFigure 2.13: Xanthates and dithiocarbamates 
This method can also be used to give xanthate and dithiocarbamate CTAs (Figure 2.13). 
Skey and O’Reilly studied this method for the synthesis of trithiocarbonate CTAs (Figure 
2.14, CTA5-CTA13), dithiocarbamates (Figure 2.14, CTA14-CTA16), and xanthates 
(Figure 2.14, CTA17-CTA19). They reported this as a high yield method for synthesizing 
functional CTAs17.   
 
121BFigure 2.14: Trithiocarbonate CTAs 
In dithioester CTAs, only one reactive site is present to react with monomer, however, 
trithiocarbonate CTAs possess two active sites. If R1 and R2 are the same, both sites are 
equally reactive and a symmetrical polymer is formed. Figure 2.15 outlines a convenient 
one-step method that is, however limited to the synthesis of a symmetrical CTA with two 
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carboxylic acids18.  If the R groups are not equally reactive, the reaction rates will of 
course differ, and indeed it is even possible that only one of the sites will be activated. 
The above methods can be used to synthesize asymmetric CTAs if desired.  The physical 
properties of a symmetrical polymer will of course differ from those of an asymmetrical 
structure.  
 
122BFigure 2.15: Synthesize the symmetry CTA with two acid group as ends 
 
46B2.2.2 Multi-functional CTAs 
Several types of multi-functional CTAs have been designed to permit the RAFT-
synthesis of more complex polymer architectures, such as star or graft polymers. The two 
major types of multi-functional CTAs are R(CS2R')n, which give star polymers, and 
R1CS2R2CS2R3, which give linear or graft polymers.  
88B2.2.2.1 CTAs for Star Polymers: R(CS2R')n  
Figure 2.16 outlines the synthesis of a trifunctional RAFT CTA that will function as a 
core molecule to give a three arm star polymer. The trifunctional CTA is synthesized by 
reacting a trifunctional carboxylic acid with a benzylic mercaptan and P4S10. However, 
this route is susceptible to side reactions and so gives low yields.13  
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123BFigure 2.16: Trifunctional star CTAs 
89B2.2.2.2 Linear Multifunctional CTAs: R1CS2R2CS2R3 
Linear multi-functional CTAs have been synthesized using a method that is similar to the 
trithiocarbonate CTA synthesis. These CTAs allow the synthesis of more complex linear 
polymeric structures19 (Figure 2.17).  
 
 
124BFigure 2.17: Linear multi-functional CTA synthesis 
 
There are two trithiocarbonate groups in one CTA. So, there are four reaction sites 
(shown in Figure 2.18) that can be utilized that arise from these two trithiocarbonate 
functional groups. The monomers will add to the site that forms the more stable radical. 
For example, in Figure 2.18, the polymerization will happen only at the site that gives the 
PhCH• (CN) radical.  
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125BFigure 2.18: Illustration of the potentially active sites and the preferred reactive site. 
Bivigou-Koumba, et al. researched this type of CTA20 in detail. They synthesized seven 
CTAs (CTA 20 – CTA 26, shown in Figure 2.19) and tested their reaction activity. They 
found that these CTAs yielded polymers with different end groups and different 
molecular weights when they were used despite following the same polymerization 
procedure. For example, a comparison of the polymer resulting from CTA 23, which has 
electron-donating methyl ether end groups, with the polymer resulting from CTA 25, 
which has electron-withdrawing perfluoro end groups, shows that the polymer from CTA 
23 has only half the molecular weight of the polymer resulting from use of CTA 25. The 
mechanism that explains why the molecular weight of the polymers from these two CTAs 
is different is shown in Figure 2.20. When initiator is added, CTA 23 breaks down into 
two other CTAs: CTAy and CTAz (Figure 2.20). This means the CTA 23 is effectively 
present at twice the concentration of CTA 25, which accounts for the molecular weight 
difference. The X group on the benzene ring of this kind of CTA decides the reaction 
orientation. H (CTA 21) and CH3O (CTA 23) as electron-donating groups, induce this 
side reaction while electron-withdrawing groups like CF3 (CTA 25) block it.   
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126BFigure 2.19: Linear multi-functional CTAs 
 
 
127BFigure 2.20: Illustration of the side reactions of CTA 21 and CTA 23 that lead to 
different polymer products from multi-functional CTAs 
 
19 
47B2.2.3 Macro-CTAs  
In RAFT polymerization, dithioester or trithiocarbonate functional groups are typically 
the preferred CTAs. Researchers have also been interested in macro-CTAs, and opted to 
prepare these by assembling smaller CTAs. For example, Wang et al. coupled hepta (3, 3, 
3-trifluoropropyl) polyhedral oligomericsilsesquioxane (POSS) with a trithiocarbonate 
CTA via reaction with its end group18a (Figure 2.21). Using this macro-CTA, they then 
prepared a new physical hydrogel. 
 
128BFigure 2.21: Use of a macro-CTA (Copied from ACS Appl. Mater. Interfaces, 2011, 3(3), 
898-909. See Appendix D for a copy of the copyright transfer agreement.) 
To gain improved polymer properties, researchers also studied coupling CTAs to solid 
supports. Polymerization of this kind, where the supported CTA is the site of a polymer 
chain’s growth, is called a “grafting-from” approach (Figure 2.22). This approach may 
require modification of the surface of the support particle, so that it can function as a 
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CTA. GNPs21, carbon nanotubes or graphene22 and resin23 have all been reported as solid 
supports for RAFT polymerization.24 
 
129BFigure 2.22: A “grafting-from” approach 
16B2.3. Polymer end-group removal and modification 
The most common process to control chain end group identity, other than selecting a 
CTA with the desired end group, is removal and/or modification of an existing chain end. 
There are four main approaches to remove or modify the CS2Z group, as illustrated in 
Figure 2.234. 
 
130BFigure 2.23: End group modifications (Adapted from Polym. Chem., 2010, 1, 149-157) 
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Thermal elimination and radical induced end group removal can yield sulfur free end 
groups. Thermal elimination has the advantage of needing no additional chemicals, but 
does require that the polymer and any functional groups on that polymer be stable at the 
reaction temperature. Thermal elimination is typically accomplished at 120-200oC. 
Postma et al. described thermolysis of RAFT-synthesized polymers in 200525 (Figure 
2.24). The weight loss profile observed by Thermogravimetric Analysis (TGA), as well 
as the mechanism of loss, were shown to depend strongly on both the RAFT agent being 
eliminated and the structure of the polymer backbone. A more detailed study was 
published in 200626. The course of thermolysis of poly(methyl methacrylate) (PMMA), 
prepared with dithiobenzoate and trithiocarbonate RAFT agents, was followed by TGA, 
1H NMR spectroscopy, and gel permeation chromatography (GPC).  
 
131BFigure 2.24: Thermolysis of RAFT-synthesized polymersm (Copied from Polym. Chem., 
2010, 1, 149-157. See Appendix D for a copy of the copyright transfer agreement.) 
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Radical induced end group removal involves the exchange between the initiator and 
RAFT end group.   This mechanism is shown in Figure 2.25.  
 
132BFigure 2.25: Mechanism of radical induced end group removal 
Another end group modification involves reaction of dithioester groups with excess 
amine or reducing agents, such as NaBH4. This is one of the most widely used and 
versatile methods of RAFT end group conversion. By this method, it is easy to convert a 
dithioester group to a thiol (-SH). This modification affords a good route to attach RAFT 
polymers to nanoparticles, such as gold nanoparticles (GNP), as shown in Figure 2.26 27. 
 
133BFigure 2.26: Metal nanoparticles attached to RAFT-synthesized polymer via thiol groups 
(Adapted from Polym. Chem., 2010, 1, 149-157)  
Polymer modified gold nanoparticles have great potential for use in advanced materials. 
Compared with other polymerization methods, RAFT polymerization has several 
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advantages for making a covalent bond to metal nanoparticles like GNPs21. There are 
three main preparative approaches for polymer/gold nanocomposites based on covalent 
linkages, as illustrated in Figure 2.27. A “grafting-from” approach was mentioned in the 
last section (Macro-CTA).  
 
134BFigure 2.27: Three main approaches for polymer/gold nanocomposites (Copied from 
Advances in Colloid and Interface Science, 2009, 149, 28-38. See Appendix D for a copy 
of the copyright transfer agreement.) 
Finally, Hetero-Diels-Alder (HDA) reactions can be used to modify the thiocarbonylthio 
group of the RAFT polymer, illustrating a RAFT-HDA click conjugation method as 
reported by Inglis, et al. at 200928. 
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9BChapter 3 End Group Polarity and Block Symmetry 
Effects on Cloud Point and Hydrodynamic Diameter of 
Thermoresponsive Block Copolymers 0Fa  
17B3.1 Introduction 
Stimuli-responsive (co)polymers are “smart” materials that undergo significant 
conformational changes when environmental conditions are changed appropriately.1 
Typical stimuli include change in temperature2, pH3, intensity of light4 and humidity5. 
These materials have been extensively investigated for biomedical uses, especially for 
drug (or other active ingredient) delivery.6 Thermoresponsive materials that possess a 
“lower critical solution temperature” (LCST) are of interest as drug delivery vehicles.2a 
The LCST is usually approximated as the cloud point (CP) of a solution, and is measured 
by a change in light transmission resulting from phase separation of the polymer from the 
solvent. 
The CP of a polymer depends on the balance between changes in enthalpy arising from 
hydrogen bonding between water and polymer and entropy when this bonding is broken 
and the water molecules are no longer ordered around the polymer7. Specifically this 
means that the CP is not only controlled by polymer composition but to a greater or lesser 
degree on the degree of polymerization, polydispersity, end groups, and architecture.8 For 
a given composition it can also vary with the concentration of the solution being tested. 
However, the magnitude of each of these effects depends on the specific polymer being 
studied.8f, 9 For example poly(N-isopropylacrylamide) (PNIPAM)9, which is probably the 
                                                 
a The material contained in this chapter was previously has been accepted for publication in Journal of 
Polymer Science Part A: Polymer Chemistry. 
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most studied stimuli-response polymer, has a CP that is relatively independent of 
molecular weight and end group. For example, the CP of PNIPAM with tert-butyl and 
methyl end groups and a 30-fold difference in molecular weight, 1.78 × 104 g/mol versus 
4.75 × 105 g/mol, had less than 1 ˚C difference, i.e. 30.83 ˚C to 30.18 ˚C. In fact, the 
influence of various chain end groups (tert-butyl, methyl, trityl and amide) on the CP of 
PNIPAM was similarly negligible, ranging from only 29.74 ˚C to 30.83 ˚C. PNIPAM 
backbones may be relatively unaffected by these changes because the repeat unit contains 
amide groups, so the effects of two end groups that both interact with the same 
homopolymer domain, are relatively insignificant. This may also explain why more 
flexible thermoresponsive polymers show more significant effects from changes in end 
group identity.10 
Studies of linear and branched PNIPAM copolymers with an imidazole co-monomer 
showed significant effects of architecture on CP.11 Depending on the monomer 
composition, the CP of the linear PNIPAM copolymers ranged from 32 ˚C to 20 ˚C, while 
the CP of the different branched PNIPAM copolymers ranged from 29 ˚C to 11 ˚C. The 
CP declined as the imidazole co-monomer content rose in both linear and branched 
copolymers. These copolymers were made using reversible addition−fragmentation 
chain-transfer (RAFT) polymerization, giving polymers asymmetric end groups, but the 
reduction in CP is primarily attributed to the imidazole groups forming stronger hydrogen 
bonds with each other. However, the branched PNIPAM copolymers also had a lower CP 
than linear PNIPAM copolymers at the same monomer ratio. This suggests that the linear 
copolymers yielded more stable micelles than did the branched ones. 
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The LCST of triblock copolymers8f (ABC type) and their aggregation behavior have been 
studied2b. One of the thermoresponsive blocks was hydrophilic and non-ionic ((Ethylene 
glycol) methyl methacrylate, EGMA), the second block (N,N-Dimethylaminoethyl 
Methacrylate, DMAEMA) was both hydrophilic and ionizable, and the third block (n-
butyl methacrylate, BuMA) was hydrophobic and non-thermoresponsive. The researchers 
found that by altering the position of the hydrophobic block, but maintaining the overall 
composition, the CP ranged from 54 ˚C to 72 ˚C. They attributed the effect to the position 
of the hydrophobic block altering the micelle structure. Another study of triblock 
copolymers with one hydrophilic block and two thermoresponsive blocks2b reported that 
changes in micellar shape and size were controlled by temperature.  
Polymers from di(ethylene glycol) methyl ether methacrylate (DEGMA Mn = 188 g/mol) 
and oligo(ethylene glycol) methyl ether acrylate (OEGA Mn = 480 g/mol) are a newer 
class of thermoresponsive materials, with excellent potential as smart biocompatible 
materials2b, 7a, 7b. These EG-based monomers can be polymerized to give polymers with 
well-defined structure, composition, and tunable LCST using controlled radical 
polymerization methods. They can also produce thermoresponsive nanoparticles (NPs) 
with EG moieties already at the aqueous interface. That allows them to be used as drug 
delivery vehicles and administered into the bloodstream without additional surface 
modification to resist non-specific protein absorption, extending survival time in the 
blood. A diblock copolymer using these monomers was thought to have value for 
“surfactant on demand” applications2b since the CP of these blocks can be tuned over a 
broad temperature range compared with PNIPAM12. 
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Overall the evidence of end group effects on CP is still somewhat conflicting, largely 
because the studies involve different polymers and copolymers, molecular weights, 
architectures, etc. However, the overall weight of the evidence suggests that micelles 
form below the CP and that hydrophobic chain ends promote this formation, while 
hydrophilic chain ends effect the hydration and organization of the (co)polymer below 
the CP.2b Nevertheless, additional research is needed, especially in the area of 
amphiphilic diblock copolymers, where there is little prior research.  
We previously12 studied the effect of diblock sequence on the CPs of linear diblock 
copolymers of DEGMA and OEGA with amphiphilic chain ends (dithioester and 
carboxylic acid). The CP of a series of copolymers, with the same block sequence, rose 
linearly as the hydrophilic block length rose, as expected. Less expected though was that 
the difference in CP of diblock copolymers with similar composition but different block 
sequence could be as little as 1.0 ˚C or as much as 28.0 ˚C. While molecular weight was 
previously shown to not significantly affect the CP13 designing amphiphilic block 
copolymers with amphiphilic end groups has a significant impact on the CP. This likely 
arises from the effects on chain conformation and how the different chain end groups 
interact with the different polymer domains.  
Here we continue our study of asymmetric end group effects on the CP of DEGMA and 
OEGA block copolymers to include additional end groups, and architecture. Our overall 
objective is to better understand these effects on amphiphilic block copolymers from EG-
containing monomers, because their CPs can be tuned over a broad range and their 
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biocompatibility and resistance to protein absorption make them increasingly important 
copolymers for drug delivery vehicles.  
Figure 3.1 shows the structure of and abbreviations used for the six CTAs that are studied 
in this paper. Illustrations of the block structures and abbreviations for the diblock 
copolymers in this work are given in Figure 3.2. 
 
135BFigure 3.1: CTAs to be studied 
 
136BFigure 3.2. This graphical illustration (blue hexagons represent the “C” end) is used to 
give a simplified image of polymer structure, and show their abbreviated designations. “S” 
as a chain end refers to a dithioester or trithiocarbonate group from the CTA, while “C” 
refers to the other chain end resulting from an asymmetric CTA. 
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18B3.2 Experimental 
48B3.2.1 Materials 
Di (ethylene glycol) methyl ether methacrylate (DEGMA Mn=188.2 g/mol) and oligo 
(ethylene glycol) methyl ether acrylate (OEGA Mn=480g/mol) were purified by passing 
over a neutral aluminum oxide column to remove residual inhibitor. 2, 2’-
Azoisobutyronitrile (AIBN) was recrystallized from ethanol. The following reagents were 
used as received: carbon disulfide, chloroform, acetone, sodium hydroxide, ligroin, 
hydrochloric acid, benzene tricarboxylic acid, benzyl mercaptan, phosphorus pentasulfide, 
1,4-dioxane, tetrabutylammonium hydrogen sulfate, hexane, S-(Thiobenzoyl)thioglycolic 
acid (DT1) 2-cyano-2-propyl benzodithioate (DT2), and 4-cyano-4-
(phenylcarbonothioylthio) pentanoic acid (DT3). The remaining CTAs were synthesized 
using procedures given below. 
49B3.2.2 CTA synthesis  
Synthesis of S, S’-bis(?,??-dimethylacetic acid) trithiocarbonate (BDAT / TC1) 
TC1 was synthesized according to a published method (Scheme 3.1).14 Carbon disulfide 
(2.74 g, 0.036 mol), chloroform (10.75 g, 0.09 mol), acetone (5.23 g, 0.09 mol) and 
tetrabutylammonium hydrogen sulfate (0.241 g, 0.071 mol) were mixed with 12 mL of 
ligroin in a 250 mL round bottom. Then NaOH solution (50%, 20.16 g) was added 
dropwise into the mixture over 1.5 h while maintaining the temperature below 25 oC. 
After the addition was complete the reaction was maintained at 22-25oC for 12 h while 
being stirred with a magnetic stirrer. Once the reaction was completed, 90 mL H2O was 
added to dissolve the yellow solids, followed by adding 12 mL of HClconc to acidify the 
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aqueous solution and yield crystalline solids. After filtration and washing several times 
by H2O, the crude compound (3.26 g, 32.11%) was purified by recrystallization in 
toluene and acetone (3:1 v/v). 1H NMR (CDCl3): 1.68 (s, -CH3, 12H), Figure A1.  
 
186BScheme 3.1: TC1 synthesis 
Synthesis of dibenzyl trithiocarbonate (TC2) 
TC2 was synthesized following the method given in a published paper15 (Scheme 3.2): 
Carbon disulfide (800 mg, 10.5 mmol) and benzyl chloride (1.27 g, 10.0 mmol) were 
added into 10 mL DMF. The reactor was placed in an ice bath and then potassium 
carbonate (1.38 g, 10.0 mmol) was added into the DMF solution. The reaction mixture 
was stirred and maintained at 40oC for 24h before being quenched by pouring into ice-
water. The mixture was extracted by ethyl acetate and dried with anhydrous sodium 
sulfate. After filtering and removing the solvent, a yellow oil product was obtained (2.60 
g, 89.66%). 1H NMR (CDCl3): 4.60 (s, Ar-CH2- 4H), 7.21-7.35 (m, Ar-H, 10H), Figure 
A2. 
 
 
187BScheme 3.2: TC2 synthesis 
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Synthesis of 1,3,5-Benzenetricarbodithioic acid (TDT) 
TDT was prepared using a known procedure16 (Scheme 3.3): Benzene tricarboxylic acid 
(2.00 g, 0.0095 mol), benzyl mercaptan (3.50 g, 0.029 mol), P4S10 (3.18 g, 0.0072 mol), 
and dioxane (150 mL) were introduced into a three-neck flask. The mixture was heated 
and maintained at reflux (100 oC) for 24 h. The solution was concentrated down to about 
20% of the original volume, and the solid waste product was removed by filtration. Then 
CH2Cl2 was added to the filtrate, and the mixture was filtered a second time.  The 
solution was then passed through a short silica gel column using hexane : CH2Cl2 (5 : 1) 
as eluent. The crude compound was then purified through a second column of silica gel 
using hexane : EtOAc ( 9 : 0.5) as eluent (yield = 12.1%). 1H NMR (CDCl3): 4.58 (s, -S-
CH2-, 6H), 7.23-7.58 (m, CH2-ArH, 15H), 8.68 (s, ArH, 3H), Figure A3. 
 
188BScheme 3.3: TDT synthesis 
50B3.2.3 Synthesis of statistical P(DEGMA-co-OEGA) (DxOy) copolymer 
A typical RAFT synthesis procedure is illustrated in Scheme 3.4. An example procedure, 
using DT3 as CTA, is as follows: DEGMA (1.88 g, 0.01 mol), OEGA (4.80 g, 0.01 mol), 
DT3 (0.056 g, 2×10-4 mol) and AIBN (0.0033 g, 2×10-5 mol) were dissolved in 1,4-
dioxane (30 mL) and the mixture was degassed with N2 for 30 min. The RAFT 
polymerization was performed at 85 oC with continuous stirring while under the 
protection of N2 gas. After 48 h, the mixture was concentrated using a rotary evaporator 
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and precipitated 3 times in cold hexane (0 oC, ice bath). The product was dried in vacuo 
at 80 oC for 3 h to obtain a viscous copolymer (5.84 g) with a yield of 86.6 %. 
 
189BScheme 3.4: Statistical copolymer synthesis 
51B3.2.4 Synthesis of diblock P(DEGMA-b-OEGA) copolymers (S-DxOy-
C(1-6) and S-OyDx-C(1-6)) by two step RAFT polymerization 
All the diblock copolymers were synthesized in a similar way, exemplified here by the 
synthesis of S-D50O50-C with DT3 (Scheme 3.5). OEGA (4.8 g, 0.01 mol), DT3 (0.056 g, 
2×10-4 mol), AIBN (0.0016 g, 1×10-5 mol) and 1, 4-dioxane (30 mL) were mixed and 
degassed for 30 min. The mixture was heated at 85 oC under the protection of N2 (g) for 
48 h. The resulting macro-CTA (S-O50-C) was isolated by concentration using a rotary 
evaporator. The crude product was precipitated 3 times in cold hexane (0oC, ice bath). 
After drying at 80 oC for 3 h in vacuo, the purified macro-CTA was obtained (4.40 g, 
90.6%). 
In the second step, the macro-CTA (S-O50-C), DEGMA (1.88 g, 0.01 mol), AIBN 
(0.0016 g, 1×10-5 mol) and 1,4-dioxane (30 mL) were mixed and degassed for 30 min, 
and then heated and stirred for 48 h at 85 oC under N2 gas protection. The reaction 
mixture was concentrated and precipitated in cold hexane (0oC, ice bath) and dried in 
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vacuo at 80 oC for 3 h. The overall yield of S-D50O50-C is 82.1% (5.53 g). They were then 
dialyzed for 3 days using dialysis tubes with a 3500 cut off. 
 
190BScheme 3.5: Diblock copolymer synthesis 
 
19B3.3 Characterization 
1H NMR spectra were recorded in CDCl3 on a Varian Unity Inova400 at 400 MHz. Fo is 
the ratio of OEGA in the diblock copolymer which was calculated using the integration 
values from 1H NMR spectra. The full details of the calculation and methods are given 
elsewhere12. The NMR spectrum in Figure 3.3 identifies key hydrogen bands, whose 
populations were calculated by Equation 3.1 for Fo: 
? ? ?? ? ??? ? ? ? ??
? ? ?? ? ??? ? ?? ? ?? ?
??????????????? ?
??????????????????? ? ?? ? ?? ? ??? 
Equation 3.1 Fo calculation 
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137BFigure 3.3 The label for each hydrogen on NMR spectra 
UV-vis spectra were recorded using a Perkin Elmer UV/vis spectrometer (Lambda 35) 
equipped with a Peltier based temperature controller. All the CPs of the aqueous 
copolymer solutions were determined at a wavelength of λ=500nm. The aqueous 
solutions were loaded into quartz cuvettes at a concentration around 5-10 mg/ml. The 
transmittance (T %) was recorded at each 1 ˚C interval, using a heating/cooling rate of 1 
oC/min. When the temperature approached the CP (ΔT% > 2%), the heating/cooling rate 
was lowered to 0.1 oC/min. At each temperature where T% was to be measured the 
solution was maintained for 2 min at that temperature before the T% was recorded to 
ensure the transmittance was stable. The test was concluded when the T% decreased to a 
minimum of 2% of the maximum T%. Then, all the transmittance values were 
normalized onto a 0-100% scale. The CP curves were then plotted with normalized 
transmittance values versus temperature.  The temperature value of the normalized 
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T%=50% was defined as the CP. The transition range (ΔT) of the copolymer was defined 
as the change of the temperature values from T%=90% to T%=10%.   
A dynamic light scattering (DLS) instrument (Coulter NP4 plus, Beckman Coulter, 
Fullerton, CA) was used to test the hydrodynamic diameter (Dh) of the copolymer in 
aqueous solutions. 
Molecular weights were determined by gel permeation chromatography (GPC, Viscoteck 
GPCmax VE2001, Malvern Instruments Ltd, UK), equipped with Viscotek 270 dual 
detector and VE 3580 RI detector. One SDV GPC Analytical column of 1000 Angstrom, 
5 Micron and dimension of 8 x 300 mm (Polymer Standard Service-USA Inc.) and THF 
were used as stationary and mobile phases respectively. 1.0 mg/mL of each polymer 
sample in THF solution was prepared and filtered through 0.2 μm syringe filter before 
injection with 100 μL for test. Poly(ethylene glycol) (Polymer Standard Service-USA 
Inc.) was used as standards for molecular weight calibration with a concentration of 1.0 
mg/mL. The calibration data are in Table A1 and Figure A4, and a representative 
spectrum is given in Figure A5. 
20B3.4 Results and Discussion 
The statistical (control) and block copolymers of OEGA and DEGMA were prepared 
using three different categories of CTAs, with the theoretical ratio of OEGA to DEGMA 
at 50:50. After the composition was confirmed to be similar to the theoretical 
composition the effects of end group and architecture were studied on nanoparticle size, 
CP, and the temperature range of the coil-globule transition. The copolymer composition, 
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Dh, CP and ΔT are all given in Table 3.1. The theoretical number-average molecular 
weight is defined as Equation 3.2: 
?????? ? ???????? ? ???????? ? ??????? ? ????????????? ??????? 
Equation 3.2 The theoretical number-average molecular weight calculation 
In Equation 3.2, [DEGMA]o, [OEGA]o and [CTA]o are the initial concentrations of the 
monomers and CTA, while M(DEGMA), M(OEGA) and M(CTA) are their molecular 
weight. The molecular weight of S-D50O50-C1 and S-O50D50-C1 were measured by 
Matrix-assisted laser desorption/ionization – time of flight (MALDI-TOF). All the 
specimens were tested by GPC and showed a molecular weight similar to theoretical but 
often a broad PDI attributed to a high molecular weight fraction not separated by the 
dialysis tube. Most of the PDIs were between 2.46-3.72 but two were above 4 and two 
were above 5 (Table S2). However, several other researchers have indicated the CPs of 
these polymers are not significantly altered by molecular weight differences9, 13, 17. That 
seems to be the case here also, as the specimens with the broadest PDI (the star polymers 
at 5.69 and 5.86, and S-D50O50-C3 at 4.71) had CPs that occurred over a narrow 
temperature range (Table 3.1). For example the star polymers collapsed over a 2.0 and 
1.2 ˚C range. Also, S-D50O50-C3 with its 4.71 PDI collapsed over a 3.5 ˚C range while S-
O50D50-C3 had a PDI of 2.47 and collapsed over a 7.5 ˚C range.  
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52B3.4.1 Measured copolymer composition  
The copolymer composition was measured using 1H NMR, and is reported as Fo. The Fo 
of the statistical copolymer is close to the theoretical 50% (47%-55%) for all the 
copolymers regardless of the CTA used. Therefore, these CTAs did not significantly 
affect the reaction of the two monomers. However, the order of monomer addition used 
to synthesize the diblocks does effect the composition of the diblock copolymers.  
Table 3.1 Copolymer composition, Dh, CP and ΔT 
CTA Sample YD  
(%)a 
YO 
(%)b 
Yover 
(%) 
Fo   
(%)c 
Dh 
(nm) 
Mn 
(th)d 
Mw 
(GPC)e 
CP 
(oC) 
ΔT 
(oC) 
 Dithioester CTAs 
 
                  DT1 
D50O50 - - 70 55 - - - 66.3 5.0 
S-D50O50-C1 38 89 75 49 152 33,612f 44,000 48.9 1.6 
S-O50D50-C1 69 85 80 68 254 33,612g 27,900 27.6 4.0 
 
                  DT2 
D50O50 - - 91 55 - - - 71.0 2.5 
S-D50O50-C2 43 92 78 46 134 33,621 38,800 54.7 1.5 
S-O50D50-C2 39 85 72 75 252 33,621 29,200 35.3 10 
      
                  DT3 
D50O50 - - 87 54 - - - 69.4 2.5 
S-D50O50-C3 60 91 82 50 143 33,679 30,900 54.2 3.5 
S-O50D50-C3 40 96 80 72 305 33,679 21,300 30.2 7.5 
 Trithiocarbonate CTAs 
 
                   TC1 
D50O50 - - 94 54 - - - 74.7 2.5 
C-O25D50O25-C 61 90 82 53 103 33,682 37,800 29.2 2.5 
C-D25O50D25-C 73 83 80 60 266 33,682 22,700 31.8 5.7 
   
                  TC2 
D50O50 - - 90 47 - - - 67.5 3.0 
Ph-O25D50O25-Ph 59 92 83 42 184 33,690 30,800 40.5 4.5 
Ph-D25O50D25-Ph 84 89 88 60 115 33,690 33,800 25.2 2.0 
 Star CTA 
   
TDT 
(D50O50)3 - - 79 50 - - - 66.1 1.2 
S-(D50O50)3-C6 55 89 80 57 95 100,734 77,100 57.5 2.0 
S-(O50D50)3-C6 43 88 75 63 130 100,734 81,400 24.6 1.2 
a Percent yield for the polymerization of the monomer DEGMA. b Percent yield for the polymerization of the monomer OEGA.     c 
The ratio of OEGA in the diblock copolymer, calculated from Equation 3.1. d Theoretical number-average molecular weight, 
calculated from Equation 3.2. e Molecular weight tested by GPC. PDI are given in Table S2. For linear polymers these ranged 
from 2.46-4.71, but for stars were 5.69-5.86. f Molecular weight tested by MALDI-TOF: Mw = 38,555 PDI = 1.12. g Molecular 
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Specifically, the Fo in S-DxOy-C (O block formed first), ranged from 46% to 57% which 
is similar to the range found for the statistical copolymers, but when we reversed the 
order of monomer addition, to produce S-OyDx-C and the D block first, Fo was even 
higher, ranging from 60% to 72%. The effect on overall copolymer composition arises 
because of the effect of the pendent EG chain (oligoethylene oxide with 8-9 pendent EG 
groups versus diethylene glycol with only 2 pendant EG groups) on the solvation and 
mobility of the growing chain end. That is, by reacting the OEGA first, the longer EG 
side chain of the OEGA allows the polymer to retain greater solvation and mobility, 
which increases the yield of OEGA. The compositional differences shown in Table 3.1 
show that OEGA consistently yields higher reaction efficiency than DEGMA. 
Conversely, when the DEGMA is reacted first, the resulting polymer is less soluble and 
this slows the reaction with respect to DEGMA. We propose this as the major reason for 
the differences in composition, although it cannot be ignored that some reactivity 
difference in the monomers can be attributed to the methyl group on the radical-bearing 
carbon of DEGMA lowering the reactivity compared to OEGA. This is because the 
methyl groups add electron density to the propagating radical chain end and perhaps 
some additional steric hindrance, but those effects are inherent to the monomer and 
independent of block sequence. 
53B .4.2 CP of Statistical copolymers 
Earlier studies have reported the effects of composition and end groups on the CP of 
OEGA/DEGA acrylates and OEGMA/DEGMA methacrylate copolymers.2b, 7b, 7c, 18 In 
our prior work we looked at OEGA/DEGMA diblock copolymers, where we used OEGA 
instead of OEGMA to enhance the hydrophobicity difference of the two monomers.12 
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The relationship between the copolymer composition and CP of the statistical from these 
two monomers followed a similar relationship of Fo/CP described by our prior work, CP 
= 0.907Fo + 20.4 (using only DT1), and first shown by Lutz et al.7a. From the linear 
relationship generated from the statistical copolymers in that work12, the CP for a 
theoretical Fo=50) should around 65.7 oC.  The CTAs used here gave slightly different 
polar end groups, and different architectures, and yet the measured CPs of the statistical 
copolymers generated here (D50O50) were similar, regardless of end group or architecture, 
ranging from 66.3-74.7 ˚C. And, the measured CP is very close to the value predicted by 
the linear relationship, using the actual composition again regardless of the end group or 
the architecture: DT1/66.3oC, DT2/71.0oC, DT3/69.7oC, TC1/74.7oC, TC2/67.5oC and 
TDT/66.1oC.  
Therefore, although end group identity and placement significantly affect the CP of 
diblock copolymers, as shown in the following section, end group effects on statistical 
copolymers are generally small. However, if the reactivity ratios of the monomers are 
significantly different so they tend towards a blocky copolymer structure an end group 
effect should still be anticipated. 
54B3.4.3 Effect of end group on diblock copolymer properties 
The six DEGMA/OEGA (1:1) diblock copolymers prepared from DT1-3 gave an actual 
Fo ranging from 0.47 to 0.55. The copolymers possessed the same hydrophobic end 
group (PhCS2) but slightly different hydrophilic chain ends. The effect of the changes in 
end group structure on the CPs was measurable but small, regardless of the hydrophilic 
chain end. The largest difference was 7.7 ˚C (S-O50D50-C2 compared to S-O50D50-C1). 
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The difference polarity was insignificant in comparison to the effects from chain end 
placement.  
 
138BFigure 3.4: CP curves of diblock copolymers from DT1-3. A: S-DxOy-C(1-3)  B: S-
OyDx-C(1-3) 
Pairing the hydrophobic PhCS2– chain end with the hydrophobic (compared to OEGA) 
DEGMA block drops the CP by 15-17 ˚C relative to the CP of the statistical copolymers 
(Table 3.1) prepared using the same CTAs. However, pairing the hydrophobic PhCS2– 
chain end with the hydrophilic OEGA block drops the CP by 36-39 ˚C. Furthermore, the 
CP curves show a relatively narrow transition (ΔT) for the coil collapse when the 
hydrophobic chain end is paired to the hydrophobic DEGMA block (Figure 3.4A), but 
pairing the hydrophobic chain end to the hydrophilic OEGA block results in the coil 
collapse occurring over a much broader temperature range (Figure 3.4B). The relative 
effect of chain end placement on CP is more clearly seen in a bar chart format (Figure 
3.5a). 
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139BFigure 3.5 (a) bar chart comparing CPs based on end group and block sequence, (b) Dh 
and CP, and (c) Dh and ΔT. 
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The relationship between the CP of linear OEGA/DEGMA diblock copolymers and 
amphiphilic end groups is clear: matching the polarity of block with end groups (i.e. 
pairing the hydrophilic OEGA block with the hydrophilic end group and the more 
hydrophobic DEGMA block with the hydrophobic end group) gives a higher CP and a 
more narrow transition than blocks paired to end groups of a different polarity.  
 
140BFigure 3.6 Affect of temperature on conformations of (a) S-DxOy-C, where chain end 
and block polarity are matched; (b) possible interactions between dithioester chain ends 
in the micellar core; and (c) S-OyDx-C, where chain end and block polarity are 
mismatched. 
Figure 3.5a-c illustrates the significant differences in CP and Dh that result from that 
pairing the hydrophobicc end to the hydrophobic DEGMA block giving S-DxOy-C 
(DT1-3) compared to when the pairing is reversed. The “mixed pairing“ of the 
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hydrophobic chain end to the hydrophilic block (S-OyDx-CDT1-3) gives a significantly 
lower CP because it results in a less orderly and efficient hydration sphere, so less energy 
is required to collapse the coil (Figure 3.6a).   
This same effect causes a clear correlation between end group pairing and the Dh (Figure 
3.5b). For example, for the three diblock copolymers where the hydrophobic chain end is 
paired to the hydrophobic DEGMA (S-DxOy-C) block the only CP detected is near ~55 
˚C and the Dh is ~ 150 nm. Conversely, for the three copolymers where the end group 
pairing is reversed, i.e. S-OyDx-C copolymers, the CP is near ~30 ˚C and the Dh is ~ 250-
300 nm. Compared to the effects of end group placement, the effect of identity of the 
hydrophilic end group on CP and Dh was quite small. Figure 3.5c shows the correlation 
also exists between chain end pairing and Dh and ΔT of the coil collapse. Pairing the 
hydrophobic chain end with the hydrophobic block results in a smaller Dh and a 
significantly smaller ΔT compared to the mixed pairing of the hydrophilic chain end to 
the hydrophobic block.   
It is clear that pairing the hydrophobic chain end with the hydrophobic block the impact 
on the CP, Dh and ΔT are substantial. All of these effects arise from a small and well-
ordered micellar structure, where the hydrophobic block is already collapsed, or nearly 
collapsed, and the hydrophilic block is well hydrated with the hydrophilic chain end 
facilitating that hydration. The chain end pairing may lead to structures something like 
that shown in Figure 3.6a for temperatures below the CP.  A structure like this could also 
account for why a separate CP is not detected for the DEGMA block in the core, since it 
is either completely collapsed or nearly so, and the CP of pure PDEGMA with similar 
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chain ends is ~25 ˚C12. Therefore, since it is so poorly hydrated we did not detect any 
additional change. The orderly structure within the hydrophobic core may also be assisted 
by interactions between the dithioester groups, such as those suggested in Figure 3.6b. 
Conversely when the chain end polarity and block polarity are mismatched, a structure 
more like that shown in Figure 3.6c may exist. This type of structure would be expected 
to have a lower CP and a greater Dh, compared to the structure shown in Figure 3.6a, 
because of a less hydrated OEGA coil within the micellar core, along with a less orderly 
collapse from the expulsion of water from the hydrated OEGA block. Because this coil is 
less ordered, the ΔT is broader than the values measured for the S-DxOy-C copolymers.  
As stated above the exact identity of the polar chain end does have some impact on the 
CP and Dh even for the same block sequence (but with difference CTAs), but this is far 
less than the effect from changing block sequence. For example, when the block 
sequence was the same the polar chain end identity resulted in no more than a 7.7 ˚C 
impact on CP (S-O50D50-C2 and S-O50D50-C1), and no more than a 53 nm impact on the 
Dh (S-O50D50-C2 and S-O50D50-C3. But when comparing the same CTA but with the 
block sequence reversed we found the CP have the of as much as 24oC (S-D50O50-C3 and 
S-O50D50-C3) and the Dh difference increased to 163nm (S-D50O50-C3 and S-O50D50-C3). 
Trithiocarbonate CTAs (TC1 and TC2) and their symmetric copolymers 
Trithiocarbonate CTAs were used to produce symmetrical triblock (O25D50O25 or 
D25O50D25) copolymers. The trithiocarbonate CTAs, TC1 and TC2, also gave symmetric 
hydrophobic or hydrophilic chain ends respectively, where the hydrophilic chain ends are 
designated as “C”, and the hydrophobic chain ends are designated as “Ph”. The thermal 
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data shown in Figure 3.7 are also summarized in Table 3.2. Model structures for these 
copolymers are proposed in Figure 3.8. 
191BTable 3.2 Effect of end groups on thermoresponse of symmetrical triblock copolymers 
Polymers CTA CP (oC) Dh (nm) ΔT (oC) 
C-O25D50O25-C TC1 29.2 103 2.5 
Ph-O25D50O25-Ph TC2 40.5 184 4.5 
C-D25O50D25-C TC1 31.8 266 5.7 
Ph-D25O50D25-Ph TC2 25.2 115 2.0 
When the chain end and terminal block polarity are matched (i.e. hydrophobic end groups 
are paired with terminal hydrophobic blocks or hydrophilic chain ends are paired with 
terminal hydrophilic blocks) the CP, Dh, and ΔT are similar. Specifically, the CP’s for C-
O25D50O25-C and Ph-D25O50D25-Ph were 29.2 ad 25.2 ˚C, the Dh’s were 103 and 115 nm, 
and ΔT’s were 2.5 and 2.0 ˚C. Therefore, these copolymers produced similar micelle size 
and hydration and an orderly coil collapse.  
 
141BFigure 3.7. Graphs of transmittance v. temperature for symmetrical triblock copolymers 
that have both (a) hydrophilic and (b) hydrophobic, symmetric chain ends. 
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142BFigure 3.8: Proposed structures for symmetrical triblock copolymers from TC1 and TC2 
in aqueous solution. 
When the chain end and block polarity of the triblock copolymers are mismatched the CP, 
Dh, and ΔT are higher than those of the triblocks with matched chain end and block 
polarity. Also, the properties of the “mismatched polarity” triblock pair differ 
significantly from each other, while the properties of the “matched polarity” triblock pair 
were very similar to each other. For example, C-D25O50D25-C has DEGMA blocks with 
hydrophilic chain ends, and has a CP a little higher than the two matched triblocks, 31.8 
˚C compared to 29.2 ˚C and 25.2 ˚C for C-O25D50O25-C, and Ph-D25O50D25-Ph 
respectively, but the CP of Ph-O25D50O25-Ph, with OEGA blocks bonded to hydrophobic 
chain ends, is 40.5 ˚C.  The two “mismatched polarity” triblock copolymers also have 
significantly larger Dh’s and broader ΔT’s than the “matched polarity” triblock 
copolymers.  The C-D25O50D25-C has a Dh of 266 nm and a ΔT of 5.7 ˚C, more than twice 
as large as those of the “matched polarity” triblock copolymers, and Ph-O25D50O25-Ph has 
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Dh of 184 nm and a ΔT of 4.5 ˚C. Possible structures arising from these mismatched 
polarity triblock copolymers in water are also given in Figure 3.8. The larger Dh of 266 
nm and ΔT of C-D25O50D25-C suggests that the short DEGMA blocks are not effectively 
collapsed and the collapse above the CP is not efficient. But the results from Ph-
O25D50O25-Ph are difficult to explain. The CP of this triblock copolymer is almost 9 ˚C 
greater than that of the other triblock structures. However, it is also important to note that 
the composition of this triblock copolymer also differed more that the other copolymers 
from the theoretical value. The Ph-O25D50O25-Ph copolymer had a Fo of only 42, while 
the Fo was 53-60 for the other triblock copolymers. Nevertheless these data do not seem 
consistent with the other findings. 
Star block copolymers (TDT) 
The CP curves of three-arm star copolymers with diblock arms having different block 
sequence are shown in Figure 3.9. Only hydrophobic chain ends were studied here 
because carboxylate groups were not successfully achieved on the terminal phenyl groups. 
The architecture of a star polymer was expected to facilitate a simple and orderly collapse 
of the arms at the CP, so it was not surprising that both copolymers had a narrow ΔT (2.0 
and 1.2˚C). The block sequence gave a somewhat greater effect on the Dh with S-
(O50D50)3-C6 giving a larger micelle (130 nm) than S-(D50O50)3–C6 (95 nm) where the 
hydrophilic blocks formed the micelle’s shell. When the hydrophobic DEGMA block is 
buried in the interior of the micelle it is more poorly hydrated than when it is the shell 
layer of the micelle, and so it is already collapsed or nearly collapsed, as illustrated in 
Figure 3.10. However, the OEGA block is well hydrated. Surprisingly though, the CPs of 
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the two star copolymers are quite different, with S-(D50O50)3–C6 having a CP that at 57.5 
˚C is nearly 33 ˚C higher than the star copolymer with the inverse block sequence, S-
(O50D50)3-C6 which had a CP of 24.6oC. It is thought that neither the OEGA nor the 
DEGMA blocks of the S-(O50D50)3-C6 copolymers are well hydrated. 
 
143BFigure 3.9: CP for Star copolymer 
 
 
144BFigure 3.10: Star polymer structure in aqueous solution 
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21B3.5 Conclusions 
Di- and triblock copolymers were easily prepared by RAFT polymerization using the 
hydrophilic OEGA and comparatively hydrophobic DEGMA with a series of different 
CTAs to study amphiphilic copolymers with different architectures and end groups. 
Linear diblock copolymers with amphiphilic end groups allowed the thermoresponse 
properties of diblock copolymers where the polarity of the blocks and chain ends was 
matched, to be compared to those of diblock copolymers with similar compositions but 
with block and chain end polarity being mismatched. Other CTAs allowed the synthesis 
of symmetrical triblock copolymers and allowed the effect of block sequence to be 
studied in conjunction with end groups that were matched or mismatched with respect to 
block polarity, and star diblock copolymers allowed the effect of block sequence with 
hydrophobic end groups to be studied in an architecture that will facilitate an orderly 
collapse of the chains.  
When comparing the diblock copolymers the effect of pairing end groups to blocks with 
different hydrophobicity is clear. Pairing the hydrophilic block with the hydrophobic 
chain end yields micelles with a lower CP and a higher Dh and ΔT. The Dh is almost 
twice as large as when the hydrophobicity of the block and chain end is better matched. 
When the blocks and chain ends are matched the hydrophilic block forms an efficient 
hydration sphere, giving the higher CP, while the hydrophobic block is effectively 
collapsed giving a smaller Dh and ΔT. However, mismatching disrupts the hydration 
giving a lower CP, and the hydrophobic block with hydrophilic chain end is also partially 
hydrated and perhaps aggregated leading to a larger Dh and ΔT. The star polymer shows a 
different trend because the architecture inhibits aggregation, so the difference in Dh and 
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ΔT is less significant but placing the hydrophilic block on the outer shell clearly allows a 
more effective and orderly hydration sphere as proven by the much higher CP. The 
triblock copolymers showed slightly more complicated result. Matching chain ends to 
block hydrophobicity/philicity yielded the smallest Dh and ΔT supporting the concept of 
the hydrophobic block being pre-collapsed and the small ΔT collapse of the hydrated 
hydrophilic block. However, when the chain ends were mis-matched to block polarity the 
results were contradictory. The larger Dh and ΔT supported a less orderly micelle 
structure with a less orderly collapse, but the CPs were not consistent. The mismatched 
triblock with hydrophilic chain ends yielded a CP nearly identical to those of the triblock 
copolymers with matched chain ends and blocks, while the triblock with hydrophobic 
chain ends paired to hydrophilic blocks gave a much higher CP, suggesting an efficient 
and orderly hydration sphere. 
Overall, the results are consistent with hydrophobic chain ends controlling micelle 
formation and hydrophilic blocks controlling hydration, and the data show that 
mismatching the hydrophilicity of the block to that of the chain end leads to disruption of 
the hydration sphere with a lowering of the CP and a broadening of the temperature range 
for the chain collapse. The architecture of a three-arm start reduced the extent of these 
effects, but was still consistent overall. The one exception to this was found for a 
symmetrical triblock copolymer with hydrophobic chain ends paired to hydrophilic 
blocks. The reason for this is not clear. Other analytical methods such as Small Angle 
Neutron Scattering will be needed to fully understand how pairing blocks with end 
groups of different hydrophobicity affect the hydration, aggregation and collapse of 
amphiphilic copolymers, but given the likely growing importance of these EG-containing 
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monomers and their thermo-response properties in the biomedical area, these materials 
are worthy of more study. 
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10BChapter 4 GNP-polymer drug delivery system 
22B4.1 Introduction 
Thermoresponsive polymers are a type of “smart” material that change phase in response 
to temperature.1 These polymers may possess a lower critical solution temperature (LCST) 
or an upper critical solution temperature (UCST).2 This research focuses on polymers 
with an LCST, and their value as drug delivery vehicles.1a, 3   
The drug delivery field has advanced significantly in recent years, with much of the focus 
being in the area of targeted delivery, which seeks to maximize delivery of the drug at the 
target site and so maximize drug efficacy.4 When the drug is potentially toxic, like a 
chemotherapy agent, an ideal drug delivery process would help to protect healthy tissues 
from damaging effects.4c  
Three key factors to design an “ideal” drug delivery process are: delivery to the right area, 
delivery at the right time, and delivery in the right concentration. These are each 
discussed in the paragraphs below. 
If a given drug is injected into the bloodstream there is no specific targeting, though there 
can be preferential adsorption into some tissues. However, drugs or drug carriers can be 
designed to carry targeting devices to give them the ability to target specific cell types or 
areas of treatment. For example, aptamers are single-stranded DNA or RNA molecules, 
and different aptamers are known to be specific to certain cell receptors.5 Cell targeting is 
particularly desirable for highly toxic drugs, such as chemotherapy agents. Effectively 
targeting the cancer cell allows pharmaceutical efficacy while protecting healthy cells 
from the chemotherapeutic agent’s toxicity.  Using a targeting ligand that is specific to a 
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single type of cell is highly effective targeting.  
Other methods are known that are less expensive but also less specific. For example, cell 
targeting may rely on differences in cell needs.  Cancer cells reproduce more rapidly than 
normal cells and so they require more glucose than normal cells.6 Because the cancer 
cells absorb so much glucose and it possesses many functional groups, glucose has been a 
convenient “vehicle” to transport other species into cancer cells.  Glucose also is 
advantageous because sugar-macromolecule conjugates readily pass through cell wall 
barriers.7  
Another reported example of cell targeting used magnetic nanoparticles.8 The magnetic 
nanoparticles, already loaded with a drug(s), are injected to the blood stream, and an 
external magnetic field is applied near the target (illness) area. This draws the magnetic 
nanoparticles to the target site. This “passive” targeting does not rely on bonding the 
nanoparticles to a particular cell type, but if there is a well-defined tumor site it can be 
fairly selective.  
The second desirable trait for the drug carrier is the ability to release the drug at a desired 
time. One way this is accomplished is by incorporating the drug in a “smart” stimulus-
response drug carrier. Thermoresponsive polymers are a good choice for these drug 
carriers, because the polymer chains of the carrier collapse and expel water at the LCST, 
which also results in the expulsion of the drug. Other smart materials that have been 
investigated as smart drug carriers include those that expel the drug in response to a 
change in pH9 or a magnetic field10. 
The third key trait for an ideal drug delivery system is the ability to release the drug at the 
proper concentration. This is perhaps the most challenging task in an ideal drug delivery 
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system, with many different variables. Of concern here is that the drug carrier should not 
release drug as it travels through the bloodstream and non-target tissues, but then must 
release the drug at the target site. Approaches to try to retain the drug in the carrier 
include designing systems that permit hydrophilic-hydrophobic interactions to for 
between carrier polymer and drugs11, capsule techniques12 and covalent bonding between 
carrier polymer and drugs13. The typical approach to releasing drug at a desired 
concentration is based on loading capacity (mass of the loaded drug / mass of the carrier 
× 100%)14 of the carriers.15 To date, the only method designed to release a specific 
quantity of drug into the blood stream at a specific time seems to be reservoir methods 
such as insulin pumps16. 
In this work we studied the drug delivery process of hybrid polymer systems prepared 
using thermoresponsive polymers and gold nanoparticles (GNPs). The thermoresponsive 
polymers are biologically safe amphiphilic diblock copolymers, with each block prepared 
from monomers that are known to give thermoresponsive polymers. The hydrophobic 
block is from diethylene glycol methacrylate monomer (DEGMA), and is intended to 
provide a suitable domain for hydrophobic drugs via hydrophobic-hydrophobic 
interactions. The hydrophilic block is from oligoethylene acrylate (OEGA) monomer, and 
is designed to stabilize the nanoparticle in the blood stream and extend its circulation 
time by preventing non-specific protein absorption as well as to possess a suitable chain 
end (here a carboxylic acid group from a RAFT chain transfer agent) that can be 
functionalized with a targeting device, such as an aptamer.  
The GNPs are included in the formulation because they are able to absorb biologically 
safe wavelengths of light and convert them to heat, and as long as the GNP size is 
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appropriate they are generally considered safe to use in the human body17. The ability to 
convert light to heat is desirable for two reasons: it allows a secondary form of 
chemotherapy called hyperthermia18, and is of particular interest here, because we can 
use this property to allow us to stimulate drug release from a thermoresponsive polymer 
with a “high” LCST (LCST >> 37 ˚C). The reason this is useful is that by using a 
nanoparticle with an LCST >> 37 ˚C we can reduce the amount of passive drug released 
in the bloodstream before the nanoparticles reach their target. If a sufficiently high LCST 
can be used to prevent all or most premature drug release in the blood, then damage to 
healthy cells and painful side effects from chemotherapy can be reduced, and once the 
nanoparticles are at the target site the appropriate light source can be used to heat the 
local tissues with the nanoparticles to above the LCST and trigger the drug release. This 
should increase drug efficacy and also allow the use of less drug.  
To test this hypothesis we studied the drug releasing properties of two “high” LCST 
nanoparticles at four different temperatures: 20 ˚C, 37 ˚C (the temperature of the human 
body), 50 ˚C and 60 ˚C. The specific steps performed to test this hypothesis were: 1)  
synthesis of two diblock copolymers with cloud points (CP, used as an approximation of 
the LCST) that were higher than 37 ˚C; 2) the thioester end group of each polymer was 
converted to the desired thiol (-SH) end group, which can bond to the GNPs; 3) graft the 
diblock copolymer to GNP nanoparticles by a grafting-to route; and 4) load a model drug 
and measure the drug release profile of the GNP-polymer nanoparticles at different 
temperatures.  
The overall hybrid design sequence is illustrated in Figure 4.1, however some minor 
changes were made to this design for this “proof-of-concept” work. Because the 
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absorption of light by gold to cause local heating is well established19, we did not use 
light as the thermal trigger since it would not be possible with our facilities to measure or 
maintain a constant temperature.  Also, because of the high cost of chemotherapeutic 
drugs, we used a less costly model drug, ibuprofen, to prove the concept of reduced drug 
release using thermoresponsive nanoparticles with a higher CP than typically studied, i.e. 
thermoresponsive nanoparticles with the CP near 37 ˚C are typically of interest11, 20. The 
most commonly used thermoresponsive polymers for biomedical applications have 
LCSTs in the range of 20-40 ˚C1a, 21. Also, much of this research used PNIPAM, with an 
LCST near 37 ˚C. We selected and prepared diblock copolymers with CPs around 50 ˚C 
and 60 ˚C. Finally, because of cost and the fact that cell work was not a part of this 
project we did not bond a targeting aptamer to the nanoparticles. While the aptamer might 
affect the CP of the final nanoparticles, again the hypothesis can be tested without the 
costly aptamer. 
 
145BFigure 4.1: GNP-polymer synthesis and drug delivery property test 
 
57 
23B4.2 Experimental  
55B4.2.1 Materials 
The chain transfer reagent (CTA), S-(thiobenzoyl)thioglycolic acid, was used as received. 
The initiator, 2, 2’-azoisobutyronitrile (AIBN), was recrystallized from ethanol. Di 
(ethylene glycol) methyl ether methacrylate (DEGMA Mn=188.2 g/mol) and oligo 
(ethylene glycol) methyl ether acrylate (OEGA Mn=480g/mol), were purified by passing 
over a neutral aluminum oxide column to remove residual inhibitor. 1, 4-Dioxane, hexane, 
1-hexylamine, dichloromethane (DCM), gold (III) chloride trihydrate (HAuCl4·3H2O) 
and sodium citrate (Na3Ct), were used as received. 
 
56B4.2.2 Syntheses: S-D50O50-C and S-D40O60-C  
The diblock copolymers, S-D50O50-C and S-D40O60-C, were prepared by the same method 
shown in Figure 4.2. For example, S-D50O50-C was synthesized using OEGA (4.8 g, 0.01 
mol), CTA (0.0424 g, 0.2 mmol), AIBN (0.0016 g, 0.05 mmol) and 1, 4-dioxane (30 mL). 
These reagents were mixed and degassed under nitrogen for 30 min, and then heated at 
85 ˚C under the continuing protection of nitrogen gas for 48 h. The resulting macro-CTA 
(S-O50-C) solution was concentrated using a rotary evaporator to isolate the crude 
produce, which was then purified by re-dissolving in fresh dioxane and precipitating (3 
times) in cold hexane (0 ˚C, ice bath). After drying at 80 ˚C for 3 h in vacuo, the purified 
macro-CTA was obtained (4.72 g, 97.4%). 
In the second step, the macro-CTA (4.72 g), DEGMA (1.88 g, 0.01 mol), AIBN (0.0016 g, 
0.05 mmol) and 1,4-dioxane (30 mL) were combined, degassed for 30 min, and then 
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heated and stirred for 48 h at 85 ˚C under continued nitrogen gas protection. The reaction 
mixture was concentrated and precipitated in cold hexane (0 ˚C, ice bath) and then dried 
in vacuo at 80 ˚C for 3 h. The overall yield of S-D50O50-C is 81.6% (5.49 g). 
 
146BFigure 4.2: Diblock copolymer synthesis procedure  
 
57B4.2.3 Reduction of the Dithioester group to a Thiol group 
The dithioester end group is reduced to a thiol using a published aminolysis method.22 As 
an example, the thioester (S) end of the S-D50O50-C is reduced as follows. Hexylamine 
(0.13 mL, 10 equiv) is added to a solution of S-D50O50-C (2.95 g, 1 equiv) in 3 mL of 
DCM. The reaction mixture is stirred overnight at room temperature under nitrogen gas 
protection. The product is precipitated into hexane and dried in vacuo at 25 ˚C for 3 h, 
giving the thiol terminated polymer, T-D50O50-C, in good yield (2.35 g, 79.7%).  
 
58B4.2.4 Synthesis of GNPs (20 nm) 
GNPs (20 nm) are prepared using a published method.23 Specifically, HAuCl4 (20 mg) is 
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dissolved in 200 mL deionized water, under vigorous stirring, and then heated to boiling. 
Then 5.0 mL of Na3Ct solution (containing 52.2 mg Na3Ct) is added dropwise into the 
solution. The solution turns to a red color and heat and stirring are continued for 2 h more.  
Then the heat is discontinued and the solution is allowed to stir overnight at room 
temperature. The resulting solution is filtered through a 0.5 μm membrane filter, and the 
GNP filtrate solution is stored in a refrigerator at 4 ˚C. 
 
59B4.2.5 Assembly of GNP-polymer hybrid nanoparticles  
The GNP-polymer nanoparticles are prepared by slowly dripping a pre-cooled copolymer 
solution (10 mg / mL, 24 mL aqueous solution) into an aqueous solution of GNPs (100 
mL, 0.2 mg/mL). The GNP: polymer mole ratio is 10:1 assuming quantitative yield of 
GNP from Procedure 3.2.4. This mixture is stirred overnight in darkness and at room 
temperature. The GNP-polymer nanoparticles are collected by centrifugation (10000 G), 
and then re-suspended in deionized water to yield 20 mL GNP-polymer solution (GNP 
concentration: 1 mg/mL). The GNP-polymer solutions are stored at 4 ˚C in darkness.  
 
60B4.2.6 Characterization of diblock copolymers and their GNP-polymer 
hybrid nanoparticles 
Copolymer composition was proven by 1H NMR. The spectra that were obtained in 
CDCl3 on a Varian Unity Inova 400 at 400 MHz. Fo is the ratio of OEGA in the diblock 
copolymer which was calculated using the integration values from the 1H NMR spectra. 
The full details of the calculation and methods are given elsewhere.24  
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The CPs of the diblock copolymers were measured by UV-vis spectroscopy using a 
Perkin Elmer UV/vis spectrometer (Lambda 35) equipped with a Peltier based 
temperature controller. All the spectra, and the CPs of the aqueous copolymer solutions, 
were determined at a wavelength of λ=500nm. The aqueous solutions were loaded into 
quartz cuvettes at a concentration (between 5-10 mg/mL sufficient to achieve a starting 
transmittance of 90%. The transmittance (T%) was recorded at 1 ˚C intervals using an 
initial heating rate of 1 ˚C/min but once the CP was approached this rate was reduced to 
0.1 ˚C/min. The test was concluded when the T% decreased to a minimum of 2% of the 
maximum T%. Then, all the transmittance values were normalized onto a 0-100% scale. 
The CP curves were then plotted with normalized transmittance values versus 
temperature. The temperature at which the normalized T%=50% was defined and 
recorded as the CP of that specimen.  
A dynamic light scattering (DLS) instrument (Coulter NP4 plus, Beckman Coulter, 
Fullerton, CA) was used to test the hydrodynamic diameter (Dh) of the nanoparticles in 
aqueous solutions. The temperature range tested was from 20 ˚C to 60 ˚C, and 
measurements made at each 5 ˚C interval using the instrument program. 
 
61B4.2.7 Loading and controlled release of ibuprofen of GNP-diblock 
copolymer hybrids 
The release profile of ibuprofen, a model hydrophobic drug, was measured in phosphate-
buffered saline (PBS buffer, pH = 7.4) at 20 ˚C, 37 ˚C, 50 ˚C, and 60 ˚C. The release 
studies were performed using the hybrid nanoparticles, GNP-D40O60-C and GNP-D50O50-
C. The procedures for the ibuprofen loading and ibuprofen release, are given for GNP-
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D40O60-C as an example. The drug is loaded by combining the GNP-polymer solution (20 
mL, solution concentration 1 mg/mL GNP, as described in section 3.2.5) with ibuprofen 
(6.0 mg). This mixture is then diluted to a final volume of 30 mL. The mixture is shaken 
and stirred for 30 min to load ibuprofen into the GNP-polymer particles, and then the 
nanoparticles and unincorporated drug are separated by centrifugation at 10000 G. The 
supernatant is collected to calculate the unincorporated ibuprofen, and allow for 
determining the ibuprofen content in the nanoparticles by mass balance. The precipitate is 
re-suspended in deionized water to give 10 mL GNP-polymer-ibuprofen solution. 
The drug release tests are performed by separating this 10 mL solution into 4 dialysis 
tubes, with each tube containing 2.5 mL GNP-polymer-ibuprofen solution (5 mg GNP 
and 1.5 mg ibuprofen). These 4 dialysis tubes are then immersed in 50 mL of PBS buffer 
for controlled release tests over 24 h at 20 ˚C, 37 ˚C, 50 ˚C and 60 ˚C independently. The 
beakers containing the dialysis tubes are sealed to maintain constant volume during 
controlled release tests. At each selected time interval, a 1.5 mL aliquot of PBS solution 
containing released drug is collected from the beaker and the same volume of fresh PBS 
buffer is added back to keep the total volume constant. This procedure is repeated until 
the release test is completed. Each reported data point is the result of 3-5 replicate 
experiments.  The amount of ibuprofen released was calculated against standard curves 
(Figure 4.3), prepared from PBS buffer. The absorption peak of ibuprofen by UV-vis 
spectrometry is at 264 nm, however, because of the low solubility of the ibuprofen, the 
highest concentration possible in PBS was 0.055 mg/mL.  
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147BFigure 4.3 Standard curve of ibuprofen in PBS buffer. 
Equation 4.1 shows how the ibuprofen concentration is determined. 
c = (A – 0.0003) / 1.9325    unit: mg / mL            Equation 4.1  
 
24B .3 Results and discussion 
Our objective was to prove the hypothesis that a high CP polymer matrix could be used 
as a drug carrier that would reduce the loss of drug occurring near the temperature of the 
human bloodstream (i.e. 37 ˚C) but achieve an efficient triggered release at a desired 
higher temperature, and to determine how much reduction in the premature drug release 
the higher CP would permit.  This release would, in principle, be induced by 
photothermal heating of the GNP-polymer hybrid nanoparticles. A CP between 50 ˚C to 
60 ˚C was postulated as a suitable range for this objective, as it was thought the CP was 
high enough to have limited release below 40 ˚C but significant release at e.g. 45 ˚C, 
which is easily achieved by photothermia. Based on prior published results24, we choose 
S-D50O50-C (CP=51.9 ˚C) and S-D40O60-C (CP=58.9 ˚C) as the two diblock copolymers 
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to be studied.  
These two copolymers were synthesized and characterized with both the dithioester and 
the thiol chain ends, then the GNP-polymer hybrids were prepared and characterized, to 
ensure similar nanoparticle size and that the CP was in the desired range; and finally the 
drug release profiles for the GNP-polymer nanoparticles were assessed above and below 
the CPs, using ibuprofen as the model drug. 
 
62B4.3.1 Characterization of the Diblock Copolymers  
90B4.3.1.1 Composition 
 
148BFigure 4.4 The 1H NMR spectrum of S-D50O50-C. 
?????????????
?????????????? ?
??????????????? ?
?????????????????????????????         Equation 4.2  
The copolymers S-D50O50-C and S-D40O60-C were synthesized at a theoretical monomer 
ratio of 50:50 and 40:60. 1H NMR (Figure 4.4) shows the typical absorbance peaks of the 
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hydrogen atoms of OEGA and DEGMA using the copolymer S-D50O50-C. The peaks 
appear at the same positions for S-D40O60-C. The actual composition of OEGA/DEGMA 
was then calculated using Equation 4.2. The specific H atoms are identified in Figure 4.4 
and Fo is the mole fraction of OEGA monomer in the polymer.)  
 
The conversion of the dithioester chain end to a thiol by aminolysis22 is evident visually 
as shown in Figure 4.5a. The dithioester copolymer gives a golden-yellow colored 
solution in methylene chloride but after the aminolysis the thiol-terminated copolymer 
solution is a pale yellow. 
 
149BFigure 4.5a Photos showing the change in color after a solution of S-D50O50-C 
(dithioester end group) dissolved in CH2Cl2 (left) is subjected to aminolysis to give a 
thiol-terminated copolymer T- D50O50-C in CH2Cl2 (right, after the product is isolated 
and re-dissolved in CH2Cl2). 
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The change in end group is confirmed by comparing the FTIR spectra of S-D50O50-C and 
T-D50O50-C (Figure 4.5b). The end groups comprise a small portion of the polymer chain, 
nevertheless after aminolysis a distinct reduction is seen in bands associated with the 
aromatic ring; i.e. the C=C bending peak at 1639 cm-1 is reduced and the aromatic C-H 
bending peak at 873 cm-1 shows that the sharp band from the dithioester appears to have 
disappeared from the spectrum of T-D50O50-C. 
 
150BFigure 4.5b FTIR of S-D50O50-C and T-D50O50-C 
 
 
151BFigure 4.6 1H NMR of S-D50O50-C (left) and T-D50O50-C (right). 
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The 1H NMR spectra also support the successful conversion of the dithioester to thiol, as 
shown in Figure 4.6. The bands at 7.4-8.5 ppm are clearer in the T-D50O50-C copolymer 
with thiol end groups than in the S-D50O50-C copolymer with dithioester end groups. 
Other differences in the spectrum of S-D50O50-C, are observed where several peaks 
belonging to the benzene ring are seen at 7.4, 8.0, 8.1 and 8.6 ppm, while in the spectrum 
of T-D50O50-C, only a single peak at 8.0 ppm is seen. Collectively, all these changes 
support the successful conversion of the dithioester chain ends to thiol chain ends.  
 
91B4.3.1.2 Characterization of T-D50O50-C and T-D40O60-C 
The experimentally determined copolymer composition along with the CP and Dh of the 
copolymers are summarized in Table 4.1. While the synthesis targeted equal block 
lengths for the OEGA and DEGMA blocks, analysis showed that the percent yield of 
OEGA was higher, and so the length of the OEGA block in the copolymer was longer 
than theoretical, while the percent yield of DEGMA in the copolymer was closer to the 
target. This is thought to be due to the fact that the OEGA block is synthesized first, and 
the pendant oligomeric ethylene glycol unit may result in some hindrance around the 
reaction site. 
192BTable 4.1 Characteristics of the Diblock Copolymers  
Sample YD(yield %) YO(yield %) Yoverall(%) Fo (%) CP(˚C) Dh(nm) 
S-D50O50-C 47 83 73.0 49 51.9 165 
T-D50O50-C - - 79.7a - 51.5 - 
S-D40O60-C 62 83 79.0 57 58.9 132 
T-D40O60-C - - 85.0a - 59.8 - 
a Aminolysis yield from S-DxOy-C, b Calculated from Equation 4.2 
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152BFigure 4.7 CP curves of a) S-D50O50-C and T-D50O50-C; and 
153Bb) S-D40O60-C and T-D40O60-C 
 
Figure 4.7 shows the CP curves of the S-DxOy-C and T-DxOy-C.  The change of end 
group has little effect on CP, but the compositional change between the two block 
copolymers caused a difference in CP of ~7 ˚C, with the S/T-D50O50-C having a CP of 
~52 ˚C and S/T-D40S60-C having a CP of ~59-60 ˚C. Because the copolymers now 
possessed the desired thiol end groups and the CPs were in the target range of 50-60 ˚C 
the copolymers were then bonded to the GNPs. 
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63B4.3.2 GNP-polymer nanoparticles  
92B4.3.2.1 Characterization of GNP-polymer nanoparticles 
Gold nanoparticles with a 20 nm diameter were prepared using established methods. 
Gold nanoparticles of this size form a ruby red solution as shown in Figure 4.8 (left). 
However, once these nanoparticles are completed with the thiol terminated nanoparticles 
the color changes to a light purple (Figure 4.8, right), and the resulting hybrid 
nanoparticles have a Dh of ~70 nm.  
 
154BFigure 4.8 Color of GNPs (left) and GNP-polymer nanoparticles (right). 
 
93B4.3.2.2 DLS analysis of GNP-polymer hybrids 
Interestingly, in this work we failed to observe the CP of the GNP-polymer hybrids, while 
in prior research in our lab the CP of the GNP hybrids was clearly visible.23. In that prior 
work, the dithioester group was reduced to thiol by NaBH4, whereas in this work 
aminolysis was used to convert the diothioester group to a thiol. Aminolysis (Figure 4.9) 
only reacts with the dithioester chain end, while reduction with NaBH4 may reduce the 
diothioester as well as some of the carbon-oxygen double bonds of the polymer side 
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chains. This may account for some changes in the thermoresponsive properties between 
the two systems based on the reduction mechanism. 
 
155BFigure 4.9 The mechanism of aminolysis. 
GNP-polymer hybrids of the type S/T-DxOy-C will naturally form a core-shell structure 
in water. The GNP is expected to form the core leaving the amphiphilic diblock to form a 
two part shell: the more hydrophobic DEGMA block will form an inner shell and the 
more hydrophilic OEGA block will form the external shell. This design is also expected 
to result in most of the hydrophobic drug loading into the internal shell, while the 
external OEGA shell aids the stabilization of the GNP-polymer hybrid nanoparticles in 
aqueous media.  The CP (Table 4.1 and Figure 4.7) of the diblock copolymers did not 
change much by converting the diothioester end group to a thiol, but it was expected that 
coupling that chain end to a GNP would have a greater effect on the thermoresponse 
properties. UV-vis failed to detect any change in transmittance, which means there was 
no aggregation when the temperature increased (Figure 4.10a). However, the DLS 
showed distinct reductions in the Dh when the temperature increased, especially from 30 
˚C to 35 ˚C. Although OEGA is more hydrophilic than DEGMA, both are hydrophilic 
monomers. When the GNPs bond to the thiol end groups and become the core of the 
polymer, this reduced the ability of the nanoparticles to aggregate (Figure 4.10b).  
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156BFigure 4.10a Temperature dependent spectra of GNP-D50O50-C 
 
157BFigure 4.10b Proposed structure differences of S-D50O50-C and GNP-D50O50-C in 
aqueous solution. 
These effects are evident in the temperature-dependent Dh data, as shown in Table 4.2.  
The 20 ˚C Dh supports the structures shown in Figure 4.10b, with S-D50O50–C having a 
diameter of 165 nm and GNP-D50O50–C having only a 74 nm diameter. Figure 4.11 
shows the differences in the temperature-dependent Dh of S–D50O50–C and its GNP 
hybrid, while Figure 4.12 compares the temperature-dependent Dh of both GNP-hybrid 
nanoparticles, GNP–D50O50–C and GNP–D40O60–C. The Dh of the free polymer, S-
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D50O50-C, is initially ~169 nm and rises to 222 nm at 30 ˚C and continues to rise until 45 
˚C, where it reaches a diameter of 279 nm. These data suggest increased aggregation of 
the diblock copolymer, which obscures the collapse of the DEGMA block, which is 
expected to be between 20-30 ˚C.  However a small decrease of ~ 20 nm is then observed 
between 45–50 ˚C, where the Dh is 257 nm. This is attributed to the beginning of the 
collapse of the OEGA block, which has a CP of 51.9˚C (Table 4.1). As the temperature 
rises further the Dh rapidly decreases to 89 nm at 55 ˚C, but then rises again to 214 nm at 
60 ˚C due to further aggregation of the polymer coils. 
193BTable 4.2 Dh of GNP-hybrid polymers and block copolymer 
Dh(nm) under different 
Temperature 
20°C 25°C 30°C 35°C 40°C 45°C 50°C 55°C 60°C 
GNP-D50O50-C 74.4 74.2 70.9 50.6 45.2 41.7 37.5 35.5 32.9 
GNP-D40O60-C 76.9 75.1 75.6 54.6 48.8 44.6 39.8 36.6 34.8 
S-D50O50-C 164.9 168.7 222.2 256.3 251.2 279.2 256.8 89.3 213.9 
 
 
158BFigure 4.11 Temperature-dependent Dh of S-D50O50–C and its GNP-hybrid nanoparticle  
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159BFigure 4.12 The Temperature-dependent Dh of the GNP-hybrid nanoparticles  
Figure 4.12 compares the temperature-dependent changes in Dh of GNP-D50O50-C with 
that of GNP-D40O60-C. Both GNP-hybrid nanoparticles have an initial size of ~ 75 nm. 
This is between that of the GNPs (20 nm) and the Dh of the free polymers (~ 165 nm for 
S-D50O50-C and ~ 132 nm for S-D40O60-C). This supports the model for the GNP-hybrid 
nanoparticles shown in Figure 20, which shows the polymer chains coiled about the GNP 
core instead of extending into the aqueous solution. From 20 ˚C to 30 ˚C, the Dh 
remained near 70 nm, however, the Dh of both GNP-hybrid nanoparticles decreased 
significantly at 35 ˚C. This is consistent with the collapse of a DEGMA block though it is 
not clear which block is collapsing.  
If the above transition is from DEGMA, then the transition of the OEGA block in the 
GNPs is unclear. The Dh of the GNP-D50O50-C and GNP-D40O60-C hybrid nanoparticles 
both show a slow continued decline between 40-60 ˚C. For GNP-D50O50-C the Dh 
declined an additional 27.2% (45.2–32.9 nm) and for GNP-D40O60-C there was an 
additional decline of 28.7% (48.8–44.8 nm). At 60 ˚C, both these hybrids have 13-15 nm 
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organic shells surrounding the 20 nm GNP core, so the copolymer seems fully collapsed 
at this temperature, which is the upper limit of the instrument. The fact that no CP was 
detected shows that there is no aggregation of the GNP-hybrid nanoparticles, but the coil 
collapse also shows that these polymers do not have the expected higher temperature 
thermo-response properties and ideally narrow transition window needed to test our 
premise of being able to significantly reduce drug release at normal body temperature and 
efficiently release the drug at higher temperature.  
 
64B .3.3 Nanoparticle drug loading and controlled release from the 
nanoparticles 
Although the thermo-response properties were not ideal the GNP-hybrid nanoparticles 
were taken to the next step, which was loading with ibuprofen and studying the release 
properties. Figure 4.13 shows the UV-vis spectrum of ibuprofen. The first spectrum is run 
at standard absorbance levels which is in the range of 0.1~0.9. The major absorbance 
band for ibuprofen is at 264 nm, while the standard Uv-vis range is from 300 nm to 800 
nm. Furthermore, the absorbance (A) of ibuprofen is very low (0.06) which is too low to 
have high quantitative accuracy, but the second spectrum in Figure 4.13 shows the 
expanded absorbance scale to obtain quantitative data, though it is expected to have 
higher than usual range of error, so the conclusions from these release data can only be 
based on trends. 
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160BFigure 4.13 Uv-vis spectrum of ibuprofen  
 
Once ibuprofen was loaded into the GNP-hybrid nanoparticles the loading efficiency was 
determined by isolating the free drug in the nanoparticle supernatant after centrifugation. 
Then, the mass balance was used to back-calculate the loaded drug. To ensure that the 
mass that was isolated from the supernatant did not contain any free diblock copolymer, 
the supernatant was dialyzed using a dialysis tube with a cutoff molecular weight was 
3500 g/mol. Therefore, both residual GNP and polymer were retained in the dialysis tube, 
and only the ibuprofen passed into the aqueous bath. After dialysis, the extracted aqueous 
solutions were combined and concentrated to 30 mL. The mass of the ibuprofen in the 
supernatant (Ms) was calculated using Equation 4.1. Based on the total mass of ibuprofen 
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(Mt), the loading efficiency and actual amount loaded were found by Equations 3.3 and 
3.4.   
Loading efficiency = (Mt – Ms) / Mt × 100%             Equation 4.3 Loading efficiency 
Actual loading drug in GNP-polymers = Mt – Ms     Equation 4.4 Actual loading amount 
As shown in Table 4.3, ibuprofen was efficiently loaded into the nanoparticles at 90.0% 
and 95.4% into GNP-D50O50-C and GNP-D40O60-C respectively 
 
161BFigure 4.14a: The release curve mass vs time: a) GNP-D50O50-C b) GNP-D40O60-C 
 
 
162BFigure 4.14b: The percent release (%) curve from drug loaded vs time:a) GNP-D50O50-C 
b) GNP-D40O60-C 
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194BTable 4.3 Loading efficiency and release data 
Sample Ibuprofen 
(mg) 
GNP 
(mg) 
Loading 
efficienc
y (%)a 
Drug release (%) at 0.5 h Drug release (%) at 24 h 
20 
˚C 
37 
˚C 
50 
˚C 
60 
˚C 
20 
˚C 
37 
˚C 
50 
˚C 
60 
˚C 
GNP-D50O50-C 1.5 2.5 90.0 16.7 23.4 34.9 39.7 57.0 58.5 84.4 94.8 
GNP-D40O60-C 1.5 2.5 95.4 17.5 31.1 33.8 41.9 47.5 64.6 65.5 95.0 
a Loading efficiency were calculated using Equation 4.3  
 
Table 4.3, Figure 4.14a and Figure 4.14b reveal several important features. Figure 4.14a 
and Figure 4.14b shows the release profiles of ibuprofen, from both GNP-D50O50-C and 
GNP-D40O60-C nanoparticles at 20, 37, 50 and 60 ˚C. They all appear to show typical 
diffusion-controlled release at all four temperatures that were tested over a 24 h period. 
The temperatures were 20 ˚C, which is below the CP for PDEGMA, 37 ˚C which is body 
temperature and above the reported CP for PDEGMA but below that of the OEGA block, 
50 ˚C which is near the observed CP of the copolymers, and 60 ˚C which is above the CP 
of both diblock copolymers. From Table 4.3 it can be seen that at 20 ˚C and 0.5 h the 
amount of drug released is similar at 16.7% and 17.5 % for GNP-D50O50-C and GNP-
D40O60-C nanoparticles respectively, which is less than 1 wt% difference. However, after 
0.5 h at 37 ˚C there is a 7.7 wt% difference in released drug with 23.4 wt% released from 
GNP-D50O50-C and 31.1 wt% released from GNP-D40O60-C. The results from 
hydrodynamic diameter (Table 4.2) showed that the thermally-triggered collapse of the 
DEGMA block occurs somewhere near 35 ˚C, so the difference suggests the D40 block 
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may have collapsed more effectively than the longer D50 block to release slightly more 
ibuprofen. The release is not thought to be due to greater diffusion-controlled release 
from the more polar GNP-D40O60-C nanoparticle because after 0.5 h at 50 ˚C the release 
from the GNP-D50O50-C nanoparticle “caught up” and slightly exceeded that from the 
GNP–D40O60-C nanoparticle, though the difference is only 1.1 wt. % greater. And then, 
after 0.5 h at 60 ˚C, which is thought to exceed the CP of OEGA block, although it was 
not detected by UV-vis, the drug release from GNP–D40O60-C exceeded that of GNP-
D50O50-C by 2.2 wt. %. These differences are too small to be definitive, but the change in 
trends near he expected CP of the OEGA blocks supports the different impact from even 
small changes in block length. 
The 24 h data also support a diffusion release that is combined with a stimulated release.   
As with the 0.5 h release data, at 60 ˚C the amount of drug released by the two different 
nanoparticle systems is nearly identical, at 94.8% and 95.0% for GNP-D50O50-C and 
GNP-D40O60-C nanoparticles respectively. However, there are significant differences 
after 24 h for the other release temperatures.  At 20 ˚C the GNP-D50O50-C had released 
9.5% more drug than GNP-D40O60-C nanoparticles, but at 37 ˚C there was little change in 
the drug release from GNP-D50O50-C nanoparticles while GNP-D40O60-C nanoparticles 
had released much more. This is the same trend as observed after 0.5 h, and suggests that 
the D40 DEGMA block releases drug at a lower temperature than the D50 DEGMA block. 
Once the temperature is raised to 50 ˚C, there is little additional drug release from the D40 
DEGMA block, presumably because this block has already released its drug, but a 
significant increase in released drug (25.9 wt. %) is now seen from GNP-D50O50-C 
nanoparticles. Therefore this higher temperature was required for collapse of the larger 
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D50 DEGMA block.  Finally, at 60 ˚C, a significant additional drug release of 29.5 wt. % 
is seen from the GNP-D40O60-C nanoparticles while an additional 10.4 wt. % drug release 
is measured from. GNP-D50O50-C nanoparticles. At 60 ˚C both nanoparticle systems had 
released about 95% of the drug, so the large difference in amount of drug released 
between 50 and 60 ˚C may be that a higher temperature was required to completely 
collapse the O60 block in the GNP-D40O60-C nanoparticles than was required to collapse 
the O50 block in the GNP-D50O50-C nanoparticles, and the complete collapse of the 
OEGA block was needed to release all the drug.  
Even though the CP of the GNP-hybrid nanoparticles was not observed by UV-vis, these 
trends in drug release are consistent with a higher CP for the OEGA block, and the CPs of 
the thiolated copolymers are consistent with this. The CP of T-D50O50-C was measured at 
51.5 ˚C while the CP of T-D40O60-C was measured at 59.8 ˚C. 
 
163BFigure 4.15 Ibuprofen release shown as release mass vs. time^1/2  
To see if the drug release data were explained by diffusion alone the data were re-plotted 
as a function of the square root of time, which should give a straight line for standard first 
order release25 (Figure 4.15). The initial drug release does appear linear, suggesting 
diffusion dominates the release initially, but the later release shows deviations from 
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linearity. These results do support two drug release mechanisms in operation. 
 
25B4.4 Conclusions 
EG-containing polymers are known to be biocompatible and acrylate and methacrylate 
polymers with pendant EG units seem likely to have a good future in the field of drug 
delivery due to their ability to be both thermo-responsive and resist protein absorption to 
extend survival time in the circulatory system. GNPs also appear to have value in 
biomedical applications such as hyperthermia. In this research we sought to combine the 
advantages of GNPs, which strongly absorb biologically safe wavelengths of light (530 
nm) and convert it to heat, with the advantages of thermo-responsive amphiphilic 
copolymers from DEGMA and OEGA. The perceived advantages of this design were that 
less hydrophilic DEGMA block was intended to provide a domain for hydrophobic drugs 
while the OEGA block was intended to provide a stabilizing and non-protein absorbing 
shell and a relatively high CP so that relatively small amounts of drug would be released 
at normal body temperatures while the GNP core could be used to heat the local 
environment to stimulate drug release at the desired time once the nanoparticles reached a 
target location.  
In this work two amphiphilic diblock copolymers were prepared and tested to determine 
the value of the design, T-D50O50-C and T-D40O60-C, with CPs of 51.5 ˚C and 59.8 ˚C, 
respectively, were prepared, and bonded to GNPs and then loaded with ibuprofen. At 37 
˚C the GNP-D50O50-C released only 23.4% of the drug after 30 mins, but at 50 ˚C 
released almost 35% after 05 h, and more than 84% after 24h. The higher length OEGA 
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block required higher temperatures for similar release. The data show that significant 
release of drug is achieved by collapsing the inner, lower CP block, but collapsing the 
outer higher CP block is necessary to achieve near quantitative drug release near 95%.  
Overall these experiments support the hypothesis and gave some promising results. 
However, better results would be expected with a drug that is somewhat less hydrophobic 
to permit higher drug loading, and a drug that gives a higher absorbance above 300 nm 
would give more accurate results. Because of this, future work should use a better model 
drug, such as 4′, 5′-dibromofluorescein or fluorescein. Better release results might also be 
expected with a DEGMA-OEGA copolymer for an inner block with a slightly higher CP 
to lower the short-term drug release while retaining a suitable domain for the 
hydrophobic drug, while maintaining an external OEGA block to ensure complete release 
at a stimulated temperature.  
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11BChapter 5 Peptide-Directed Self-Assembly of 
Functionalized Polymeric Nanoparticles: Multiple Drug 
Loading Ability 1Fb 
26B5.1 Introduction 
Efficient tissue regeneration often depends on the delivery of various drugs (i.e. low or 
high molecular weight agents including growth factors) at appropriate rates to implanted 
cells. Therefore, understanding the relationship between tissue engineering, scaffolding 
systems, and drug delivery is crucial for the design of functional scaffolds for the desired 
applications.1 For example, skin regeneration usually requires the delivery of a complex 
mixture of growth factors and cytokines, (e.g. fibroblast growth factor, keratinocyte 
growth factor, vascular endothelial growth factor and interleukin 1α) within the wound to 
promote cell proliferation and migration for wound healing.2 Therefore, the fabrication of 
sophisticated scaffolding systems with the ability to physically support cells and at the 
same time deliver an appropriate “drug cocktail” at an appropriate rate to promote cell 
growth and health is an important advance for tissue engineering.  
Self-assembled peptide nanofiber scaffolds have gained in popularity compared to 
scaffolding from other polymers, possibly because they are perceived as non-toxic and 
biodegradable, and the porous fibril structures are thought to be similar to extracellular 
matrix (ECM) and so will aid cell attachment.3 Also, these materials can assemble in situ 
into a hydrogel at physiological environment.3l, 3m The first reported self-assembling 
“designer peptide” was EAK16-II (AEAEAKAKAEAEAKAK), isolated from a yeast 
                                                 
b The material contained in this chapter was previously published in Macromolecular Bioscience. See 
Appendix C for documentation of permission to republish this material. 
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protein, zuotin.4 EAK16-II spontaneously self-assembles into stable β-sheets in aqueous 
conditions across a broad range of temperature and pH, even in the presence of 
significant quantities of a denaturing agent, such as urea or guanidium hydrochloride.5  
The self-assembling process is driven by the hydrophobic interactions of alanine (A) 
domains and ion-pair interactions between negatively charged glutamic acid (E) side 
chains with positively charged lysine (K) side chains. The importance of the strong ion-
pair interaction for successfully forming the β-sheet was supported by investigation of a 
complementary pair of designer peptides, that were self-repulsing but possessed strong 
mutually attracting peptide sequences where one of the pair possessed a sequence with 
positive charges (Ac-WKVKVKVKVK-amide) and the other sequence with negative 
charges (Ac-EWEVEVEVEV-amide).6 On mixing this pair of complementary peptides, a 
rapid assembly into a viscoelastic hydrogel occurred at a concentration as low as 0.25 
wt. %. This hydrogel retained mechanical strength, even after repeated shear-induced 
breakdowns, due to the electrostatic interactions. The strong electrostatic and selective 
interaction between the opposite charges demonstrated one of the key merits of using ion-
complementary β-sheet motifs. 
Other designer self-assembling peptide hydrogels (e.g. RADA16-I or II) have also been 
studied and they, along with EAK16-II, have been widely used as both controlled drug 
delivery systems and 3D scaffolds.7 The drug delivery method is typically a simple 
physical mixing of a drug into the peptide mixture during the gel formation,7-8 but it can 
also be chemically bonded onto the C-terminal or N-terminal.9 Sometimes a combination 
of both methods is used to load multiple active agents.10  
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However, these methods all have significant limitations with respect to the quantity of 
drug(s) that can be incorporated, as well as the real possibility that the incorporated 
drug(s) may have a detrimental effect on the subsequent self-assembly process or the 
mechanical stability of the formed hydrogel. There is also a very limited ability to control 
the release rate of drugs with different properties. Therefore, the peptide itself must be 
designed in conjunction with the specific drug(s) that will be incorporated. Moreover, the 
effective distribution of multiple drugs in scaffolds is not easy to achieve.  
In previous work from our group, we demonstrated a new approach to fabricate tissue 
scaffolding, prepared by peptide-directed self-assembly of polymeric nanoparticles into 
fibers and 3D scaffolds, to address these limitations.11  This type of assembled 
scaffolding system is achieved by functionalizing amphiphilic triblock copolymers with 
self-assembling ionic complementary peptides (P1-ABA-P1 and P2-ABA-P2). The 
triblock copolymer (ABA) is assembled into a core-shell nanoparticle to contain a desired 
drug, while the carboxylic chain ends are modified by appropriate peptides (P1 or P2) to 
give the peptide-functionalized core-shell nanoparticles (e.g. P1-NP-P1 and P2-NP-P2). 
That paper described the synthesis and assembly of the nanoparticle fiber scaffolds, 
demonstrated the ability to contain low and high molecular weight model drugs, and 
proved the incorporation and controlled release of insulin from the peptide conjugate 
nanoparticles and the assembled scaffold. The first paper also described other potential 
variables that affected scaffold morphology and the advantage of being able to design and 
make assembled nanoparticle scaffolds where different desired drugs could be 
incorporated into a nanoparticle that had a size, composition, and release rate that were 
designed for that drug. The size of the particles is controllable and can range from nano- 
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to microparticle, and can be designed to swell significantly or only a little in aqueous 
media depending on the composition and size of the shell in core-shell particle scaffolds. 
When the peptide-functionalized nanoparticles are combined they assemble into 
continuous “nanoparticle fibers” and, given time, 3D scaffolds form that have a “sponge-
like” appearance in aqueous solution.  
The nanoparticle self-assembly approach is expected to possess the ability to: (1) 
incorporate multiple drugs, regardless of that drug’s hydrophilicity or hydrophobicity, 
within nanoparticles in the scaffolding; (2) independently control the release of each drug 
from a nanoparticle whose composition is designed for that specific drug; (3) control the 
distribution of the different drugs within the scaffold, by the assembly sequence; and (4) 
be able to be introduced into a patient by injection followed by controlled self-assembly 
of the scaffold in situ. These abilities provide this type of assembled fiber system with 
significant advantages over electrospun fiber scaffolding as well as peptide-only 
scaffolding. 
Here we illustrate the self-assembly behavior and versatility of peptide-functionalized 
nanoparticles using different particle sizes that can alter scaffold porosity and affect 
mechanical stability, and also show the ability to load and independently control the 
simultaneous release of three drugs within a single scaffold. We used two hydrophobic 
model drugs (4’, 5’-dibromofluorecein as moderately hydrophobic and fluorescein as 
somewhat more hydrophobic), and a slightly hydrophilic model drug (nitrofurazone). The 
assembly sequence of the self-assembled nanoparticles, having already been loaded with 
drugs, is illustrated in Figure 5.1. 
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164BFigure 5.1 Illustration of the assembly of a 3-nanoparticle system 
27B5.2 Experimental 
65B .2.1 Materials 
The ionic complementary peptides (P1: H2N-TTTT-AEAEAEAE-amide and P2:  H2N-
TTTT-AKAKAKAK-amide) was described in previous work. 1-Vinyl-2-pyrrolidinone 
(VP) (?99%), methyl methacrylate (MMA) (99%), 1,4-dioxane (99+%), 2,2?-
azobisisobutyronitrile (AIBN) (98%), dimethyl formamide (DMF, 99.9%), phosphate 
buffered saline (Biotech) and model drugs of nitrofurazone (NF), 4’,5’-
dibromofluorescein (DBF) and fluorescein (FL) were purchased from Sigma-Aldrich. 
Ethyl alcohol (200 proof, anhydrous) was from PHARMCO-AAPER, and diethyl ether 
(anhydrous) and dimethyl sulfoxide (DMSO) were from Mallinckrodt Baker Inc. 
(Phillipsburg, USA). VP was purified prior to use by passing through a neutral alumina 
column. MMA was distilled before use. All other reagents were used as received. 
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Ultrapure deionized water (>17.6 M?-cm) was obtained from MEG-PURE SYSTEM 
(MP-190 LC). 
 
66B5.2.2 Synthesis of Amphiphilic Triblock Copolymers 
Amphiphilic triblock copolymers of PVP-b-PMMA-b-PVP, with reactive carboxylic acid 
terminals (HOOC-ABA-COOH), was synthesized by RAFT polymerization using S,S?-
bis(?,??-dimethylacetic acid) trithiocarbonate (BDAT) as a chain transfer agent (CTA) 
and 2,2?-azobisisobutyronitrile (AIBN) as the initiator, as described in previous work.11 
Briefly, the polymerization was done in two steps to build up the amphiphilic block 
copolymer. In the first step the hydrophilic block (PVP) was prepared in dioxane at 70?C 
(24 h under nitrogen atmosphere) using the following ratio of reagents: [M]o: [BDAT]o: 
[AIBN]o=1000:5:1. The product was precipitated in cool diethyl ether to obtain the PVP 
solids. The precipitation was repeated 3 times to remove any unreacted monomer. The 
polymer containing the hydrophilic block was vacuum-dried at 50 ?C for 12 h. In the 
second step, the hydrophilic polymer was used as a macro-CTA to copolymerize with 
MMA in a dioxane/DMF (4:1 v/v) solvent mixture with additional AIBN added (0.0012 
g). The reaction was continued at 70 ?C (48 h) under nitrogen atmosphere to obtain the 
amphiphilic triblock copolymer. The as-made copolymer solution was purified by 
precipitating in cool diethyl ether 3 times to remove unreacted residues and vacuum-dried 
at 50 ?C for 12 h. The reactant ratios and the theoretical data of triblock copolymer were 
shown in Table 5.1. 
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195BTable 5.1 Reactant ratios and theoretical data of triblock copolymer 
Macro-CTA [M]o:[CTA]o:[I]o XN 
PVP 1000:5:1 200 
Copolymer Mass Ratio 
(Macro-CTA )o:(MMA)o 
XN/XM 
PVP-b-6PMMA-b-PVP 1:3 200/66
6 
Theoretical molecule: PVP100-PMMA666-PVP100 
 
67B5.2.3 Coupling Reaction of Copolymer with Peptide (P1 and P2) 
The synthesized peptides (P1 and P2) were coupled with the desired amphiphilic 
copolymer to form peptide-copolymer conjugates. The coupling reaction was performed 
between the carboxylic acid terminals of the desired polymer and the amine terminal of 
the desired peptide using 2-(7-aza-1-H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium 
(HATU) as the coupling agent, as reported previously.11 In this work the polymer 
molecular weight differs from that in the previous work, so the reactant quantities and 
ratios are slightly different that reported previously. The process for the PVP-b-
12PMMA-b-PVP system is described as an example. The copolymer (1.0 g, ~1.6 x 10-5 
mol) was dissolved in DIPEA/DMF (8.0 mL, 0.9 M DIPEA in DMF) at room 
temperature in a 25 mL three neck round bottom flask with magnetic stirring. The 
reaction solution was degassed for 15 min with nitrogen gas and then HATU (0.012 g, 
3.2 x 10-5 mol) was added to activate the carboxylic acid groups. P1 (0.10 g, 8.2 x 10-5 
mol) was pre-dissolved in DMF (5.0 mL) in a glass vial, and then transferred into the 
activated copolymer solution via syringe. The reaction was continued for 45 min at room 
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temperature with magnetic stirring and nitrogen gas bubbling through the solution. P2 
was similarly coupled with a second batch of copolymer. The peptide-copolymer 
conjugate was precipitated in cool diethyl ether and centrifuged to remove unreacted 
chemicals. The precipitates were washed 3 times to obtain purified conjugate solids, and 
dried under reduced pressure for 12 h at 50 ?C before storing in a sealed vessel in the 
refrigerator at 4 ˚C. 
68B5.2.4 Self-Assembly Study of Peptide-Copolymer Conjugates in 
Aqueous Solution 
All peptide-copolymer conjugates nanoparticles were first self-assembled in separate 
aqueous solutions to form the peptide-functionalized nanoparticles designated P1-NP-P1 
and P2-NP-P2. The P1-NP-P1 and P2-NP-P2 nanoparticles, bearing complementary 
peptides were then combined to further assemble into 1D nanoparticle fibers and 
eventually formed 3D scaffolds as directed by the ionic complementary assembly 
between P1 and P2.  
The assembly of the nanoparticles into nanoparticle fibers was accomplished in three 
steps as follows. First the P1-copolymer conjugates (20 mg) were dissolved in DMSO (2 
mL) to give a clear precursor solution, and this precursor solution was slowly injected 
(0.4 mL/min) into weakly basic deionized water (10 mL, pH 9.0, adjusted by 1 M NaOH 
solution), using a 31 G syringe, while being stirred at 700 rpm by a magnetic stirrer. This 
resulted in the first level of assembly to give the P1-NP-P1 suspension. After completing 
the injection of the precursor solution, the magnetic stirring was continued for 30 min and 
then sonicated 3 minutes to form a stable peptide-nanoparticle suspension. Separately, in 
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the second step, the P2-copolymer conjugates were dissolved in DMSO to form another 
precursor solution and then injected into weak acidic D.I. H2O (10 mL, pH 5.4, adjusted 
by 1 M HCl) and also sonicated for 3 min to give a P2-NP-P2 suspension. 
The individual nanoparticle suspensions were formed in basic (pH 9.0) and acidic (pH 
5.4) D.I. H2O to better ionize the carboxylic acid side groups of P1 and amine side groups 
of P2 to bear negative and positive charges respectively. This ensures that the newly 
formed nanoparticles bear complementary peptides that are also self-repulsive. However 
we can also accomplish assembly at neutral pH or PBS (pH 7.4).11 The typical yield for 
these scaffold systems ranges from 90-95%. 
69B5.2.5 Controlled Release Testing 
The selected peptide-copolymer conjugate is dissolved in DMSO together with the 
desired drug to give a precursor solution. For example, for a two-drug scaffold, we 
prepared NF/P1-PVP-b-6PMMA-b-PVP-P1 (38 mg + 5.0 wt. % NF) in 1.5 mL DMSO 
and DBF/P2-PVP-b-6PMMA-b-PVP-P2 (38 mg + 5.0 wt. % DBF) in 1.5 mL DMSO. 
The NF/P1-copolymer precursor solution was then slowly injected into deionized water 
(10 mL) to give an NF-loaded core-shell nanoparticle suspension (NF-loaded P1-NP-P1 
suspension). A DBF/P2-copolymer precursor solution was similarly prepared and 
injected into deionized water (10 mL) to give a DBF-loaded self-assembled core-shell 
nanoparticle suspension (DBF-loaded P2-NP-P2). The DBF-loaded P2-NP-P2 suspension 
was then slowly injected (23 G syringe) into the NF-loaded P1-NP-P1 suspension with 
gentle magnetic stirring at 400 rpm for 1h to give a uniform mixture, which was then 
allowed to self-assemble into a 3D nanoparticle scaffold with magnetic stirring at 100 
rpm and settled to the bottom of the vial. 
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The nanoparticle scaffolds were collected by centrifugation at 4000 rpm for 20 min to 
isolate any NF and DBF that were not captured by the nanoparticles or just loosely 
adsorbed onto the nanoparticle surfaces. They were then washed with fresh D.I. H2O (2.0 
mL each time). The centrifugation and washing process were repeated two additional 
times. All supernatant fractions were combined to collect all uncaptured NF and DBF, so 
that the actual loading (wt %) of NF and DBF in nanoparticles was calculated based on 
Equation 5.1. The washed scaffold solids were then used to set up the controlled release 
study.  
%100.% int ???
? lenanoparticloadeddrug
druguncaptureddrugial
W
WW
wtActual     
Equation 5.1 Actual loading efficiency (wt. %) 
The three drug loading process was similarly accomplished, but in this case, the ratio of 
P2-NP-P2 (DBF loaded) to P1-NP-P1 (NF loaded) to P2-NP-P2 (FL loaded) was set up at 
1:2:1 wt. /wt. to achieve the loading of three drugs into a single scaffold. Briefly, 
DBF/P2-PVP-b-6PMMA-b-PVP-P2 (19 mg + 5.0 wt.% DBF)/DMSO (0.75mL) solution, 
NF/P1-PVP-b-6PMMA-b-PVP-P1 (38 mg + 5.0 wt.% NF)/DMSO (1.5mL) solution and 
FL/P2-PVP-b-6PMMA-b-PVP-P2 (19 mg + 5.0 wt.% FL)/DMSO (0.75mL) solution 
were prepared and each was separately injected into D.I. H2O (5 mL, 10 mL and 5 mL 
correspondingly) to give the three model drug-loaded nanoparticle suspensions. The 
DBF-loaded P2-NP-P2 suspension was slowly injected into the NF-loaded P1-NP-P1 
suspension with gentle magnetic stirring at 400 rpm for 1h to give a uniform mixture. 
Due to the ratio of P1-NP-P1 to P2-NP-P2 was 2:1, at this stage the self-assembled 
nanoparticle fibers will favor “nanoparticle trimers” terminated with P1 on both ends. 
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Then, the third drug-loaded nanoparticle suspension (FL-loaded P2-NP-P2 suspension) 
was slowly injected into the above P1-terminated nanoparticle fiber suspension, restoring 
‘peptide stoichiometry’, and gentle magnetic stirring was continued to advance the 
assembly and give the triple drug loaded scaffolding.  
The triple drug-loaded scaffold solids were isolated and washed with fresh D.I. H2O (2.0 
mL each time, washing 2 additional times to collect all free model drugs in supernatant. 
Again the actual drug loading (wt. %) was calculated according to Equation 5.1 after the 
uncaptured drugs were quantified by UV spectrometry. 
Both the two and three-drug loaded scaffold solids were set up for controlled release tests 
over 24 h at 37 oC in PBS media. The scaffold solids were re-dispersed in PBS (5.0 mL) 
and then transferred into dialysis tubing, which was then immersed into 100 mL of PBS 
buffer in a beaker at 37 oC. The beaker with dialysis tubing was sealed to keep total mass 
constant during controlled release tests. If solvent loss was detected, D.I. H2O was added 
to keep total mass consistent. At each time interval, a 1.5 mL aliquot of PBS solution 
with released drug was removed from the beaker and the same volume of fresh media 
was added to keep the total volume at 100 mL. This procedure was repeated until the 
controlled release test was completed.  
 
28B5.3 Results and Discussions 
70B5.3.1 Proof of self-assembling by DLS 
The hydrodynamic diameter of the system after different levels of nanoparticle assembly 
is shown in Figure 5.2. After initial assembly to give individual peptide-functionalized 
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nanoparticles the two nanoparticles have a similar size (Figure 5.2 a and b) at 174 nm and 
167 nm. After 1 h the nanoparticle size prepared by combining a 2:1 ratio of P1-NP-P1 
and P2-NP-P2 possessed a hydrodynamic diameter measured by DLS that was consistent 
with a “trimer”, assuming a roughly “linear” conformation. After 20 h the size (Figure 
5.2c and Table 5.2) was not significantly different indicating stoichiometric control, 
consistent with a step-growth process. We then restored stoichiometry to this system by 
adding the requisite equivalents of P2-functionalized nanoparticles, and re-measured the 
size again after 1 h and 20 h of reaction.  
 
165BFigure 5.2 DLS test showing the hydrodynamic diameter resulting from different stages 
of self-assembly. (a) and (b) Hydrodynamic diameter of the individual nanoparticles P1-
NP-P1 and P2-NP-P2; (c) Hydrodynamic diameter of an assembled nanoparticle trimer 
form by mixing P1-NP-P1 with P2-NP-P2 at 2:1 ratio after 20 h of assembly time; (d) 
Hydrodynamic diameter of an assembled nanoparticle fiber by mixing P1-NP-P1 with 
P2-NP-P2 at 1:1 ratio after 20 h of assembly time. 
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We saw additional growth after 1 h and still further growth after 20 h (Table 5.2). While 
the chain conformation is not expected to approximate linear as the assembly sequence 
gets longer, here we approximate the chain length of five nanoparticles (XN ~5, using a 
nanoparticle diameter of 170 nm and assuming a linear chain), which suggests that 
significant chain extension has not occurred. The slow growth in size is consistent with 
step-growth processes, but here we attribute the low chain extension to be primarily due 
to the dilute conditions required for a DLS test. However, the importance of perfect 
stoichiometry to achieving a high degree of assembly cannot be ignored. Either slow 
growth or any error in peptide stoichiometry, or some combination of both, will result in 
a much shorter nanoparticle chain. Here, we know that the system was dilute that is a 
contributor to the small chain size. On the other hand, the non-uniform copolymer chain 
length and possibly different coupling reaction between P1 and P2 with the copolymer 
will give variables for P1- and P2-copolymer conjugates, leading to deviation of 
stoichiometric control between P1- and P2- functionalized nanoparticles. This is 
considered as another contributor to the low chain growth. So, the nanoparticle assembly 
process requires more exploration by adjusting the ratio between P1- and P2-
functionalized nanoparticles to achieve an optimized condition for a perfect 
stoichiometric system to follow step growth principle to give more effective nanoparticle 
chain growth. 
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196BTable 5.2 Hydrodynamic diameter of a scaffold “Trimer” and the full scaffold after 
restoration of peptide-functionalized nanoparticle stoichiometry. 
Samples Assembled NP name Scaffold Assembly 
time (h) 
NP Size (nm) 
P1-PVP-b-6PMMA-b-PVP-P1 P1-NP-P1 -- 174±4 
P2-PVP-b-6PMMA-b-PVP-P2 P2-NP-P2 -- 167±2 
P1-NP-P1 : P2-NP-P2 
Ratio 2:1 
NP “Trimer” 
1 518±22 
20 531±19 
P1-NP-P1 : P2-NP-P2 
Ratio 1:1 
NP fiber 
1 620±10 
20 827±9 
71B5.3.2 Drug delivery calculation 
Three model drugs of nitrofurazone (NF, λmax=375nm), 4′,5′-Dibromofluorescein (DBF, 
λmax=502nm) and Fluorescein (FL, λmax=490nm) were incorporated into assembled 
nanoparticle scaffolds to test the multiple drug loading ability and control over release 
rate of each loaded drug. The chemical structures of the three molecules are shown in 
Figure 5.3. Among these three drugs, NF is considered a slightly hydrophilic model drug 
(more soluble in PBS than DBF and FL), and both DBF and FL are moderately 
hydrophobic model drugs, but DBF contains two bromide groups, and thus is more polar 
than FL.  
     
166BFigure 5.3 Chemical structure of the model drugs. (a) Nitrofurazone (NF), (b) 4′,5′-
Dibromofluorescein (DBF) and (c) Fluorescein (FL). 
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Measurement of the simultaneous release of multiple drugs from a single scaffold is not a 
trivial process, since many drugs will have some absorption at the same wavelengths. To 
try to find the suitable wavelengths for measuring simultaneous drug release several sets 
of standard curves were made to determine the quantity of drugs released from the 
scaffolds. Figure 5.4 shows the three standard curves of NF, DBF and FL in PBS buffer 
(pH 7.4) with concentration ranging from 0 to 0.5 mg/100mL, and measuring the drug at 
different wavelengths. 
 
167BFigure 5.4 Standard curves of NF, DBF and FL used for the quantitative determination of 
the multiple released drugs (Test done in PBS). 
A two drug-loaded scaffold was prepared for the simultaneous controlled release of NF 
and DBF. The quantity of released drug was calculated using the equations given below, 
where X1 is the concentration of the released NF at each time interval and X2 is the 
concentration of the released DBF. A1 is the absorption of λ =375nm and A3 is the 
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absorption of λ =502nm. The absorption of each λ gives the sum of the absorption of each 
single model drug. Based on this, we can get two equations: 
λ =375nm, A1=1.083 X1 + 0.046 X2 + 0.008 
λ =502nm, A3=1.759 X2 + 0.009 
After solving this equations, we can get the concentration for each model 
drug: 
X1 = [A1 - 0.008 - 0.046 X2] / 1.083  
Equation 5.2a The concentration calculation of model drug (NF) 
X2 = (A3 - 0.009) / 1.759                      
Equation 5.2b The concentration calculation of model drug (DBF) 
NF, DBF and FL model drugs were used in the triple drug-loaded scaffold for controlled 
release testing. We calculate the concentration of each drug in the drug-loaded scaffold 
using the equations at three different wavelengths. X1 is the concentration of the released 
NF at each time interval, X2 is the concentration of the released DBF and X3 is the 
concentration of the released FL. A1 is the absorption of λ =375nm, A2 is the absorption 
of λ =490nm and A3 is the absorption of λ =502nm. According to the standard curves, we 
can get these equations at each wavelength:  
λ=375nm, A1=1.083 X1 + 0.046 X2 + 0.081 X3 + 0.009   
λ=490nm, A2=1.302 X2 + 2.561 X3 + 0.019   
λ=502nm, A3=1.759 X2 + 1.381 X3 + 0.013 
Solving these equations, the concentration for each component is:  
X1 = (A1 - 0.046 X2 - 0.081 X3 - 0.009) / 1.083 
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Equation 5.3a The concentration calculation of model drug (NF) 
X2 = (A2 – 2.561 X3 – 0.019) / 1.302 
Equation 5.3b The concentration calculation of model drug (DBF) 
X3 = (1.351A2 – A3 - 0.013) / 2.079 
Equation 5.3c The concentration calculation of model drug (FL)  
All samples from the release data were diluted (sample: PBS = 1:2) for testing the 
absorption by UV-vis. Each data point shown is the average of three tests.  
72B5.3.3 Release data discussions 
The quantity of each drug released from the scaffold was measured for the two- and 
three-drug system at selected time intervals as shown in Tables 4.3 and 4.4. 
197BTable 5.3 Released quantity of model drugs from the two-drug scaffold (in 100ml PBS 
buffer). 
Time X1/mg X2/mg 
0 0.000 0.000 
0.5 0.026 ±0.007 0.094 ±0.002 
1 0.043 ±0.004 0.194 ±0.003 
2 0.084 ±0.008 0.410 ±0.021 
3 0.096 ±0.007 0.565 ±0.005 
6 0.125 ±0.006 0.900 ±0.070 
12 0.122 ±0.006 1.080 ±0.120 
24 0.114 ±0.009 1.140 ±0.076 
Uncaptured 1.540 ±0.109 0.123 ±0.016 
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198BTable 5.4 Quantity of each model drug released from the three-drug scaffold (in 100 mL 
PBS buffer). 
Time/h X1/mg X2/mg X3/mg 
0 0.000 0.000 0.000 
0.5 0.026±0.011 0.054±0.011 0.095±0.013 
1 0.057±0.014 0.128±0.028 0.208±0.019 
2 0.086±0.012 0.241±0.050 0.376±0.025 
3 0.102±0.008 0.333±0.056 0.500±0.039 
6 0.122±0.011 0.487±0.022 0.706±0.118 
12 0.120±0.012 0.561±0.027 0.820±0.062 
24 0.116±0.011 0.607±0.031 0.911±0.014 
Uncaptured 1.789±0.014 0.058±0.000 0.075±0.002 
Any uncaptured drug in the supernatant was similarly determined by the above 
quantitative analysis method. The results are also shown in Table 5.3 and 4.4, labeled as 
Uncaptured. Using the uncaptured drug quantities, the loading efficiency of each drug 
and its actual loading (wt. %) were calculated by Equation 5.1.  
In sum, the quantity of each drug that was not captured during nanoparticle preparation, 
and the quantity of released drug at each time interval, were determined by UV-vis 
spectrometry using calibration curves prepared from standard solutions of NF, DBF and 
FL. The drug concentration ranged from 0.001 mg/mL to 0.005 mg/mL, and was 
measured against the standard curves using Beer’s Law equations (Figure 5.4) and 
Equation 5.2a-b and 4.3a-c. After the calculating by Equation 5.1, Table 5.5 gives the 
loading efficiency and actual loading (wt. %) of the model drugs in both the two and 
three drug loaded scaffolds.  
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199BTable 5.5 Loading efficiency of model drugs in two-drug and three-drug nanoparticle 
scaffolds. 
Scaffold Model Drug NP Pair Theo. Loading wt. % Act. Loading wt.% Loading eff. % 
2 Drug 
NF P1-NP-P1 5.0 1.2 23 
DBF P2-NP-P2 5.0 4.7 93.8 
3 Drug 
DBF P2-NP-P2 5.0 4.7 94.2 
NF P1-NP-P1 5.0 0.53 10.6 
FL P2-NP-P2 5.0 4.6 92.5 
 
One of the major advantages of the peptide-assisted nanoparticle assembly is to impart 
self-assembled polymeric nanoparticle scaffolds with the ability to load desired quantities 
of more than one type of drugs into a single scaffold, without hindering the scaffold 
assembly, while still retaining control over the release rate of each drug. We tested a 
scaffolding system with up to three model drugs and confirmed the incorporation and 
sustained release of each drug.  Prior work proved that we could assemble scaffolds from 
nanoparticles with different composition of the nanoparticles, incorporate drugs and 
proteins into the nanoparticles and manipulate their release rates.11 Therefore this proof-
of-concept study focused only on the simultaneous release of multiple drugs, so the 
overall nanoparticle composition was held constant.  
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168BFigure 5.5 Cumulative release of model drugs from multiple drug-loaded self-assembled 
nanoparticle scaffolds over 24 h. (a) NF and DBF release from a two drug-loaded 
scaffold, mg per 100 mL PBS buffer; (b) wt.% cumulative release from two drug-loaded 
scaffold. (c) NF, DBF and FL release from a triple drug-loaded scaffold, mg per 100 mL 
PBS buffer; (d) wt.% cumulative release from triple drug-loaded scaffold. 
 
The two-drug and three-drug loaded scaffolds were prepared as described in experimental 
section. Table 5.5 summarizes the theoretical loading (wt. %) of the model drugs (NF, 
DBF, FL) and their loading efficiency. When preparing the drug-loaded nanoparticle 
scaffolds, the nanoparticle assembly is based on an assumption that the individual 
nanoparticles (P1-NP-P1 and P2-NP-P2) possess approximately same mass which are 
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assembled from P1-PVP-b-6PMMA-b-PVP-P1 and P2-PVP-b-6PMMA-b-PVP-P2, so 
that the nanoparticle end functional group numbers of P1 and P2 for nanoparticle chain 
extension through step growth principle can be controlled by measuring the nanoparticle 
mass to give stoichiometric control. But actually, owing to the presence of polydispersity 
of the as-made block copolymer, the inconsistent mass of the individual nanoparticles is 
unavoidable, so it is required to further optimize the mass ratio of P1-NP-P1 and P2-NP-
P2 to achieve a better stoichiometric balance of P1 to P2 for more efficient control over 
nanoparticle chain growth if this system is applied to practical application. Here we 
preliminarily tested the abilities of multiple drug loading and controlled release over each 
drug. The controlled release profiles are shown in Figure 5.5. 
The release profiles in Figure 5.5 show that the model drugs undergo a burst release in 
the first 6 h, followed by a stable release, a typical diffusion controlled release. Analysis 
of the cumulative % release along with the data in Table 5.5, suggest that the release rates 
of the model drugs have a complex dependency on several factors. The quantity of drug 
loaded into the scaffold is the major factor influencing the release rate and the amount of 
drug released. This is evidenced by the fact that the moderately hydrophobic model drugs 
possess a higher loading efficiency (DBF: 93.8 to 94.2 % and FL: 92.5 %) and show 
faster release rates than the slightly hydrophilic drug (NF), which possessed a low 
loading efficiency of 10.6 % and 23 %.  This result is explained by the higher loading of 
the drugs producing a greater concentration gradient between the nanodevices and their 
surrounding environment (here is PBS media), driving the drug diffusion into the media 
in a faster rate. And also higher loading quantity leads to a more porous structure of the 
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nanoparticles, which is considered to increase the channels for both aqueous penetration 
and drug release. Such phenomena are also seen elsewhere.12  
In principle, hydrophilic NF is more easily released into PBS media due to its higher 
solubility than that of moderately hydrophobic DBF, but Figure 5.5a shows only 26.3 wt% 
of NF released versus 58.2 wt% of DBF over 24 h. This result implies a second important 
factor that also influence drug release rate, the molecular interaction between drug 
molecules and polymer matrix. This is evidenced by NF release behavior from the two 
drug-loaded and triple drug-loaded scaffolds (Figure 5.5a and c). As Table 5.5 shows, the 
actual loading wt% of NF in the two drug-loaded scaffold is more than two times as in 
the triple drug-loaded one (1.2 wt% versus 0.53 wt%), where the nanoparticle mass for 
NF-loading is same in both scaffolds (see experimental section), but  controlled release 
test shows that the NF cumulative release quantity is remained constant (0.11 ± 0.01 mg) 
over 24 h (Table 5.3 and 4.4), though the wt% cumulative release of NF is doubled due to 
the difference of the initial loading quantity (Figure 5.5b, d). This means the interaction 
of NF molecules with polymeric matrix, especially with hydrophilic shell (PVP shell), 
dominates the release rate (showing constant releasing behavior), but such interaction did 
not enhance the loading efficiency of NF in the nanoparticle scaffolds.  
According to the chemical structure of the model drugs (Figure 5.3), the moderately 
hydrophobic model drugs (DBF and FL) possessed higher loading efficiency (92.5 % to 
94.2 %) because they were more easily incorporated into the hydrophobic domains 
(PMMA core) and also could effectively distribute into the hydrophilic shell (PVP shell) 
via polar-polar interaction due to both molecules possessing certain amount of polar 
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functional groups (i.e. OH and C=O). This can be seen from the burst release behavior of 
both model drugs, followed by a stable release (Figure 5.5a and c). However, it is 
interesting to note that FL was released by 94.3 % over 24 h while DBF showed much 
lower release rate (58.2 % in Figure 5.5b and 61.7 % in Figure 5.5d). Again, this result 
supports that the molecular interaction plays significant role on release rate. The only 
structural difference between DBF and FL is the two bromide groups on DBF (Figure 
5.3), which is considered to increase the molecular polarity and thus enhance the 
molecular interaction with polymeric matrix. Such enhanced polarity will also increase its 
solubility in PBS buffer, but it is not dominant for DBF release rate. So this means it is a 
competitive process of solubility and molecular interaction with polymer matrix to 
influence the release rate of a drug in a core-shell nanoparticle. Which one is dominant 
depends on the drug property and nanoparticle composition. 
The release rates of the drugs from the scaffolds tested here show that there are several, 
complex, factors influencing their release. Gaining a more complete understanding of 
these complex factors influencing release will allow a scaffold designer to efficiently 
tailor the release of drugs from core-shell nanoparticle scaffolds. Besides the obvious 
variables such as drug loading quantity and choice of a nanoparticle composition suitable 
for each drug (since release is influenced by drug solubility and molecular interaction 
with the polymers), other variables include core-shell ratio and nanoparticle size. Yet 
additional variables worth testing in future include the porosity of the scaffold, the ability 
to combine different size nanoparticles within a single scaffold system and/or different 
compositions of nanoparticles that contain the desired drug(s). 
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29B5.4 Conclusion 
A novel self-assembled fibrous nanoparticle scaffolding system was demonstrated that 
employs peptide-functionalized polymeric nanoparticles that self-assemble into 
continuous ‘nanoparticle-fibers’. This type of nanoparticle scaffold combines the 
advantages of nanoparticles’ abilities to contain and control the release of active 
ingredients (demonstrated here with model hydrophobic and hydrophilic drugs) along 
with the ability of peptides to assemble into controlled 1D, 2D, and 3D structures. This 
versatile system allows the simultaneous incorporation of multiple drugs, which, when 
properly controlled, gives substantial ability to design a scaffold with the desired quantity 
of a drug or other active agent, to tailor the release rate of that active agent, and allows 
control over how these nanoparticles are distributed within a scaffolding system. The 
assembly process is step growth, and so treatment of each nanoparticle as if it were a 
monomer should allow all the same control over number average degree of 
polymerization and sequence or block length control according to the rules of step growth 
processes as outlined by Wallace Carothers. The versatility of this fundamental technique 
can be expanded to other materials or coupling techniques.  The materials and peptides 
used here were not cytotoxic to fibroblast cells, but that the surfaces require additional 
modification to improve cell adhesion if it is desired, possibly by immobilizing cell 
adhesion ligands on the polymeric nanoparticle surfaces. In this work we also noted that 
the designer peptide self-assembly is easily converted into an amorphous aggregate after 
washing with aqueous solution, which was due to an overly water-soluble peptide 
structure, so alternative designer peptides with less solubility might promote a lower 
critical concentration to form stable self-assembled peptide nanofibers with enhanced 
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mechanical strength while longer and more mobile peptide motifs might yield longer 
nanoparticle fibers. In principle this approach can be further advanced to give both 
temporal and spatial control over the distribution of the drug-containing nanoparticles to 
allow blocks of nanoparticles with a given drug, or nanoparticle gradients to be formed in 
the scaffolds, while also yielding an injectable system. 
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12BChapter 6 Polymer Modification of Fish Scale and their 
Nano-mechanical Properties2Fc 
30B6.1 Introduction 
Throughout history humans have used and benefitted from nature’s materials, benefitting 
from the properties their hierarchical structure gives them (e.g. hides, feathers, wood), 
and then learning to separate component parts (e.g. gelatins, keratin, cellulose) for other 
uses. More recently we have sought to study ever more complicated natural designs in 
natural materials and to replicate properties inherent to those designs with other, often 
synthetic, materials, giving rise to the science of biomimetics. Perhaps the best known, 
and most advanced example of this, is learning to produce superhydrophobic and self-
cleaning surfaces from the study of lotus leaves.1 In recent years certain types of fish 
scales have elicited great interest because of their exceptional properties.2 The two most 
studied scale structures are those of the arapaima3 and alligator gar4, whose scales have 
been described as dermal armor.5  
Fish scales are designed to protect the body from predators or other damage, and to 
reduce friction as they move through water, but even though all scales serve these 
functions there can be significant differences in scale composition, design, shape, and 
size.4, 6 Of the four major categories of scales (i.e. cycloid scales found on salmon and 
carp, ctenoid scales found on fishes such as bass, placoid scales found on sharks and rays, 
and ganoid scales found on sturgeon and gars), the most studied from the perspective of 
                                                 
c The material contained in this chapter was previously has been submitted to the Journal of Applied 
Polymer Science. 
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materials or polymer scientists are the ganoid scales of alligator gar (Atractosteus 
spatula)4 and the ctenoid scales of the arapaima (Arapaima gigas)3.  
Most of the materials-focused research on fish scales has studied the hierarchical design 
of individual scales7, the mechanical properties of individual scales7b, 8, mathematical 
studies to simulate the mechanical properties9 and the arrangement of scales to see how 
they work together as an assembly10.  
The objective of those studies is to gain a fundamental understanding of how scales 
achieve their exceptional properties, and presumably to be able to apply that 
understanding to reproduce and exceed those properties using synthetic materials, e.g. for 
body armor or other armors. That is why the bony scales of the alligator gar are the most 
studied.4, 9 However, while the design of alligator gar scales is important from a 
fundamental perspective, it is not a food fish. So its scales will never be an abundant 
waste resource.  
The ctenoid scale of the arapaima gigas is the other well-studied fish scale. These scales 
have been studied because they allow this South American fish to resist predation by the 
piranha.5, 11 This scale has two main layers. The top layer is a calcium deficient 
hydroxyapatite (HAP) layer, also called the biomineral layer, because it contains organic 
components in addition to HAP. It has a similar composition to dentin.3 The second layer 
is flexible and consists of smaller layers of alternating arrays of collagen fibers 12, with 
the layers arranged at 90˚ to one another. The overall thickness of the scales can vary, but 
the alternating collagen layers are ~50 μm thick. The collagen fibers in these stacked 
layers are ~1 μm, and these are made up of individual collagen fibrils of ~100 nm. The 
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collagen layer has many methods to dissipate energy without failure, include the ability 
for the individual 50 μm layers to slide past one another without damage. The arapaima is 
a food fish in South America, but it is also not an abundant resource and not a North 
American species. One study looked at the scales (ctenoid) of a North American food fish, 
the striped bass (Morone saxatilis).11 Those researchers studied the toughness and failure 
modes of the scale and found that it resisted penetration more effectively than either 
polystyrene or polycarbonate. 
With annual fish harvests estimated at ~140-176 million tonnes, the mass of waste scale, 
assuming it is just ~1 wt% of the fish, is still at least 1.4 million tonnes. Therefore scale 
waste is abundant but underutilized. When they are used industrially or in research the 
typical interest is in harvesting their components for individual use, i.e. HAP from the 
biomineral layer 6a, 8b is harvested by high temperature alkaline treatment, and collagen is 
harvested using HCl to remove the biomineral layer followed by additional re-fabrication 
methodologies for subsequent biomedical uses.13 The recovery of basic components from 
biowaste is valuable and consistent with a “bio-refinery” approach, but it also sacrifices 
all the properties built into the scale’s hierarchical design.  
Lignocellulosic materials are the most abundant biomass under investigation. Studies of 
this biomass and its uses include separation and chemical modification of components in 
a standard bio-refinery approach14, but also size diminution of the lignocellulosic and 
surface modifications15, and chemical and energy treatments to isolate cellulose 
nanocrystals16 and nanofibrils17. Just as cellulosic materials are used in different forms 
and for with different modifications, fish scales may also offer a range of opportunities 
for use beyond simply extracting their basic components. Because of the hierarchical 
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design of fish scales, with the hard HAP biomineral surface and the tough collagen layer, 
there are numerous opportunities for selective physical and chemical modifications. On 
one surface and a hydroxyapatite (HAP) biomineral layer, allowing the selective 
manipulaton of structure and properties. 
Our long-term interest in scales is to find uses for fish scale waste that can take advantage 
of their hierarchical structure. To that end we focus on an initial study of the cycloid 
scales of the lake whitefish (Coregonus clupeaformis), in the family of Salmonidae, 
which is an abundant food fish harvested throughout Canada and the northern United 
States. The material properties and potential value of scales of North American fish are 
almost never studied, with the exception of a study on the ctenoid scales of a bass11. In 
fact the material properties of cycloid scales seem to be almost unstudied, with only one 
paper found, used X-ray microscopy techniques, to study the collagen fiber structure of 
the cycloid scales of the red seabream (Pagrus major), harvested from the Sea of Japan.18 
In this work we provide the first study of the nanomechanical properties of the relatively 
unstudied cycloid type of fish scale, and the first investigation of the ability to selectively 
chemically alter the different layers of the fish scale. It should be noted that we found one 
prior study that used scales as a support for TiO2 nanoparticles for photocatalysts19, but 
the chemical modification of fish scales is unstudied. The intention of this work is to 
show the potential to “build on” and benefit from the hierarchical design of scales rather 
than simply destroy the structure for its components. We hope that these studies will 
begin to point the way to applications for fish scales other than simply for isolatable 
components. Two of the most likely applications are as packaging additives and 
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composite reinforcements. As these applications, and many others, would likely benefit 
from modifying the interface, our initial studies looked at the effects of surface 
modifications on the spectroscopic and nanomechanical properties.   
One prior study looked at unmodified scales as reinforcement in epoxy but found only 
modest improvement in tensile and flexural strengths.20 Although they reported H-
bonding between the epoxy and the scale this may have been insufficient for effective 
load transfer. Therefore, appropriate surface modification to enhance load transfer may 
yield better results. 
 
31B6.2 Experimental 
73B6.2.1 Materials 
Whitefish scales (salmon family with cycloid scales) were used as received, harvested 
from fish taken from Lakes Superior, Huron and Michigan. Hydrochloric acid (HCl, 
concentrated), sodium hydroxide (NaOH), tetraethyl orthosilicate (TEOS), methyl 
methacrylate (MMA), oligo (ethylene glycol) methyl ether acrylate (OEGA, 
Mn=480g/mol), tert-butyl methacrylate (MA) and 2,2’-azoisobutyronitrile (AIBN) were 
purchased from Sigma-Aldrich. Clorox® was purchased from a local store. MMA and 
OEGA were purified by passing over a neutral aluminum oxide column to remove 
inhibitor. AIBN was recrystallized from ethanol. The other chemicals were used as 
received.  
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74B6.2.2 Fish scale modifications 
94B6.2.2.1 Cleaning fish scale surfaces (FS and FS-W) 
As-received fish scales (FS) had been previously hand-washed in water. These scales 
were immersed in D.I. water (ca. 2 g fish scale in 20 mL D.I. water), and placed in an 
ultrasonic bath for 90 min at 42 kHz. These fish scales were decanted and rinsed three 
times with D.I. water, then air dried at room temperature, and used as unmodified control 
specimens. These scales are differentiated from the as-received FS scales by the 
designation FS-W. 
95B6.2.2.2 Fish scales treated by acid or base (FS-H and FS-OH) 
Scales (2 g) were immersed in 20 mL of a 3.3% (w.t.%) HCl (aq) solution, then placed in 
an ultrasonic bath for 90 min at 42 kHz. The fish scales were decanted and rinsed three 
times with D.I. water. The fish scales were air dried at room temperature, and are 
designated as FS-H. The same procedure was used for scales that were immersed in a 3.3% 
(w.t.%) NaOH (aq) solution. These scales are designated FS-OH. 
96B .2.2.3 Fish scales treated by Clorox® (FS-C) 
Scales (FS) were immersed in a Clorox® solution (2 tsp per 1 gallon of water, active 
agent NaOCl) with stirring for 2.5 min. The scales were decanted, rinsed three times with 
water, and then air dried. These scales are designated FS-C. 
97B6.2.2.4 Fish scales modified with SiO2 (FS- SiO2 and FS- SiO2-C) 
Fish scales were immersed in TEOS and acidified water (H+/Si = 8:1 mol:mol). The 
mixture was stirred at room temperature for 60 min. The scales were decanted, and the 
surface rinsed with D.I. water. The scales were then placed in a convection oven at 70oC 
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and heated for 4 hours. These scales are designated as FS-SiO2. For comparison, a second 
specimen was prepared in the same manner, except it was soaked in the same TEOS/HCl 
solution for only 30 min. It was also placed in a convection oven at 70oC and heated for 4 
hours. These scales are designated as FS-SiO2-C.  
200BTable 6.1 Summary of designations 
Scale Designation Description of Scale Processing 
FS As-received scales. Hand washed in water 
FS-W FS scales with additional washing in water in an ultrasonic bath (40 kHz) 
1.5 h. 
FS-H FS scales 3.3% (w.t.%) HCl(aq) solution in an ultrasonic bath (40 kHz) 
for 1.5 h. 
FS-OH FS scales 3.3% (w.t.%) NaOH(aq) solution in an ultrasonic bath (40 kHz) 
for 1.5 h. 
FS-C FS scales washed 2.5 min in Clorox® solution of 2tsp/gal water 
FS-SiO2-C FS scales immersed in TEOS/HCl (Si/H+ 8:1) for 0.5 h, followed by heat 
treatment (70 ˚C/4 h). 
FS-SiO2  FS scales immersed in TEOS/HCl (Si/H+ 8:1) for 1 h, followed by heat 
treatment (70 ˚C/4 h). 
FS-PMMA FS scales immersed for 1 h in monomer containing 1 w.t.% AIBN 
initiator, followed by heat treatment (70 ˚C/4 h).          
FS-POEGA FS scales immersed for 1 h in monomer containing 1 w.t.% AIBN 
initiator, followed by heat treatment (70 ˚C/4 h).          
FS-PMA FS scales immersed for 1 h in monomer containing 1 w.t.% AIBN 
initiator, followed by heat treatment (70 ˚C/4 h).          
 
98B6.2.2.5 Polymer-modified fish scales (FS-PMMA, FS-POEGA, FS-PMA) 
Fish scales were immersed in a selected monomer (MMA, OEGA, or MA) into which 
AIBN (1 w.t.%) had been dissolved. The fish scales in were stirred in the solution for 60 
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min. Excess monomer was decanted and then the scales were heated at 70 ˚C for 4 h in a 
convection oven. These scales are designated as FS-PMMA, FS-POEGA or FS-PMA. All 
the modified fish scales are shown in Table 6.1. 
75B6.2.3 Preparation of Scale Cross Sections  
Scales were embedded in an epoxy resin (EpoxiCure; Buehler, Lake Bluff, IL, USA) 
inside a cylindrical mold. The embedding resin was allowed to harden (24 hours, room 
temperature), and then removed from the mold. Each sample was polished using silicon-
carbide paper under a continuous water jet to wash away abraded material. The 
specimens were polished until a cross section near the center of the scale was reached.  
76B .2.4 Modulus Using AFM 
 
169BFigure 6.1 The diagram illustrates the different scale structures and modified scales. 
From left: an assembly of scales showing their overlap (top left); a representation of an 
individual scale before and after washing, and the alternating collagen layers. The second 
row represents the expected changes in structure resulting from chemical modifications. 
All AFM experiments were carried out with a Dimension ICON AFM system (Bruker, 
USA). Peakforce Tapping mode was applied for all the nano-mechanical measurements 
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and topography imaging21. RTESPA silicon cantilevers (Bruker, USA) were selected. 
The spring constant was calibrated using Sader’s methods22 before each experiment, and 
the calibrated values were in the range from 32 to 49 N/m. In Figure 6.1, all the samples 
shown in the diagram will be tested by AFM. An additional background and explanation 
of the Derjaguin-Muller-Toropov (DMT) modulus is given in Appendix B. 
32B6.3 Results and Discussion 
77B6.3.1 Visualization and Analysis of Unmodified Scales: FS and FS-W 
 
170BFigure 6.2 Surface of FS control scales imaged by optical microscope and AFM. The 
probe tip in the optical images has a 40 μm diameter. AFM images show a 6μmx6μm 
area. At bottom a topographical AFM image maps the roughness of the biomineral layer. 
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Cycloid fish scales have two types of layers: a biomineral (largely hydropxyapatite) 
upper surface layer and a collagen layer, consisting of alternating layers of rods at the 
interior and bottom surface of the scale. As Figure 6.2 shows, the biomineral surface is 
rough with regular ridge features of ~30–40 μm that alternate with depressions having a 
similar or slightly smaller diameter. These ridges are formed as the scales grow, like 
growth rings on a tree, so there is also a difference in scale thickness with the newer 
edges being thinner than the scale center. While these are the dominant features of the 
scales, there are other small variations in scale features depending on the scale’s 
placement on the fish and with respect to other scales. The top of the scale that is exposed 
is generally rougher than the top of the scale that is overlapped by other scales. Most of 
these features are similar to those that have been described for other types of scales by 
others 5, 23. However the scale surface that is covered by other scales shows unusual 
features that appear cell-like but seem to be too small for cells (≤ 1 μm). The 
topographical AFM image at the bottom of Figure 6.2 shows these features are oval to 
circular. Interestingly, these features are not observed in any scales other than the FS 
scales, including FS-W scales that were cleaned by ultrasonic washing. We suspect these 
features are associated with the cell’s mucus layers, which possess the mucus/goblet cells 
24, so these features might be dried remains of those cells. However, at this time we do 
not know what these features are. 
Figure 6.3 shows a cross-section of an FS-W scale. The optical image shows multiple 
layers of collagen bundles with different orientations as evidenced by the light and dark 
grey striations. The AFM images confirm these collagen layers and the projecting 
collagen bundles made up of individual collagen rods are clearly seen at two different 
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angles in the AFM images. These alternate in a similar manner to those reported for the 
ctenoid scales of arapaima gigas5. From AFM1, the collagen is from one side to another 
and almost at the same surface. From AFM2, the collagen is from back to front, so the 
tops of the collagen rods are observed. This shows that the hierarchical structure was 
maintained after the ultrasonic washing and the collagen rod structure, which imparts 
toughness to the scales, appears undamaged.  
 
171BFigure 6.3 Cross-section of FS-W showing the different layers of collagen 
 
78B6.3.2 Selectively degraded scales: FS-H, FS-OH and FS-C 
99B5.3.2.1 Changes in composition and structure by FTIR 
Before we could understand how our modifications were changing the two main domains 
of the scales we first needed to characterize the two main domains of the unmodified FS 
and FS-W scales. Because we wished to see if our modifications were preferential to the 
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biomineral or collagen layers of the scales, so that we might “build” on the existing 
hierarchical design of the scales, we analyzed the top and bottom surfaces of the scales 
separately rather than simply grinding up the scales for analysis as is typically done. 
Figure 6.4 shows the FT-IR spectra of the intact scale’s upper biomineral layer and lower 
collagen layer for the FS (Figure 6.4a) and FS-W (Figure 6.4b) scales. We next studied 
the effects of a mild acidic (Figure 6.5a), basic (Figure 6.5b), and oxidative soak (Figure 
6.5c), on each surface. 
 
172BFigure 6.4 FTIR of FS (a) and FS-W (b) 
The FTIR spectra of the top and bottom surfaces of FS are shown in Figure 6.4a, where 
all the protein bands of the collagen side are observed: i.e. the N-H stretching band (3288 
cm-1), the C=O stretch band (1633 cm-1) and the N-H bending band (1540 cm-1). The 
biomineral surface shows the expected hydroxyapatite PO43- bands at 1012 cm-1, 592 cm-
1, and 550 cm-1.  
The FTIR spectra of the top and bottom layer of the FS-W scales, which were subjected 
to a low energy ultrasonic wash, are also seen in Figure 6.4b. There is little obvious 
difference in the two spectra, although the relative size of the amide N-H bending band 
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(1540 cm-1) compared to the amide C=O stretching band (1633 cm-1), and a small 
reduction in one of the alkyl C-H bands near 3000 cm-1 may have occurred on the bottom 
(collagen) surface. However, as stated previously, we expected the ultrasonic washing to 
remove residual mucous layer components from FS, yet the bands in the biomineral layer 
do not appear to have changed except for loss of a very small band near 3000 cm–1. As 
these components are a small part of the composition and are expected to be 
predominantly proteins and glycoproteins, they probably make little distinctive 
contribution to the FT-IR spectra. 
 
173BFigure 6.5 IR for soaked samples: FS-H (a), FS-OH (b) and FS-C (c) 
Figure 6.5a and 5.5b compare the spectra of acid-treated (FS-H) and base-treated scales 
(FS-OH). Acidic solutions degrade or destroy the biomineral layer, leaving the collagen 
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layer behind13d. In contrast, basic solutions degrade or decompose collagen, leaving the 
biomineral layer behind.13b  
The top surface of FS and FS-W show strong absorptions from PO43-, but these bands are 
significantly reduced in FS-H scales, with the top surface showing only a very small band 
at 1012 cm-1. The spectra of both the top and bottom surfaces of the FS-H include 
obvious bands from amide bonds of collagen. These bands are barely evident in the top 
surface of FS and FS-W. Therefore, the mild wash removed a significant portion of the 
biomineral layer, but not all of it, and it appears to have left the collagen layer intact. 
Because some of the biomineral layer is left, the extent of the biomineral layer that is 
removed might be adjusted by a shortened soak cycle to allow properties of the collagen 
layer relative to the biomineral layer to be modulated. 
Similarly, the use of NaOH is an established technique to remove the collagen layer to 
recover hydroxyapatite13b since it decomposes collagen faster than the biomineral layer. 
After soaking the scales in NaOH(aq) under mild conditions the FTIR spectra of the top 
and bottom surfaces of FS-OH retained the absorption bands observed in FS and FS-W, 
so each layer retained significant character of the original surfaces. However, by 
comparing the relative areas of key amide bands it is clear that the collagen layer has 
been significantly reduced. Again, the relative degree of degradation of the collagen layer 
relative to the biomineral layer can be adjusted by the soaking conditions (time, 
temperature, concentration), and because base degrades the collagen layers more slowly 
than acid degrades the biomineral layer, its removal is likely to be more easily adjusted 
than that of the biomineral layer.  
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The FTIR of FS-C was also observed. Both bottom and top surfaces were similar to the 
FS and FS-W. However, relative to the collagen peak, the hydroxyapatite peaks (PO43-) 
had strengthened. At the same time, the fish scale was visibly thinner and more brittle. 
The observations show that even a mild Clorox® oxidation was highly destructive to 
both layers, though the collagen layer appeared to be more effected than the biomineral 
layer.  
100B6.3.2.2 Changes in Equilibrium Moisture Content (EMC)  
The EMC of the scales was significantly increased by modifications that selectively 
degraded either the biomineral or the collagen layer (Table 6.2, and Figure 6.6), with FS-
H and FS-OH possessing EMCs of 15.5 and 12.0% respectively. This is a significant 
increase in EMC when compared to that of FS scales at just 6.2%. Interestingly FS-C 
scales, where both layers were degraded, had nearly the same EMC uptake as the FS, at 
6.9%. Equally surprising is that the FS-W scales also showed a significant increase in 
EMC compared to FS, and rose to 11.8%. We expected that the ultrasonication would 
remove any residual mucus layer on the scales, but so too should the Clorox® soaking, 
and the FS-C scales absorbed only 6.9% moisture. These data show that the 
ultrasonication step altered the structure of one or both layers, resulting in nearly 
doubling of the moisture uptake. We saw that the cell-like features of FS were not present 
in those of FS-W, which suggests that the change in the scales accounting for the 
increased EMC was associated with the biomineral layer. But, those features were not 
observed on the FS-C scales either. It is possible that the ultrasonication affected the 
collagen layer, perhaps denaturing the collagen rods, but without additional data we 
cannot identify the reason for the significant difference in EMC. At this point the only 
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clear structural difference we have observed between a low and a high EMC scale is 
associated with a change in the biomineral layer. 
 
174BFigure 6.6 EMC of modified fish scale (Soaked with different solution) 
201BTable 6.2 EMC of modified samples at 48 hours (80% relative humidity)  
Modified Fish Scale (w.t.%) 
FS 6.2±0.5 
FS-W 11.8±0.6 
FS-H 15.5±0.2 
FS-OH 12.0±0.2 
FS-C 6.9±0.2 
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79B6.3.3 Polymer-modified scales 
101B6.3.3.1 Changes in composition by FTIR 
 
175BFigure 6.7 IR for polymer-modified fish scale: FS-SiO2 (a) and FS-POEGA (b) 
Four different modifications of the scales employed chemical changes that added 
polymer material to one or both scale layers. The first scale modification resulted from 
soaking the scales in an acidic solution of TEOS followed by heating the scales to 
produce SiO2 in situ. This modification was non-selective, but significantly favored the 
biomineral layer over the collagen layer. The fact that both layers were modified (Figure 
6.7a) was demonstrated by the appearance of a Si–O–Si at 1055 cm–1 in the spectra of 
both the biomineral and collagen surfaces of the FS-SiO2 scales. But the modification 
was more extensive at the biomineral surface because the PO43- bands of the biomineral 
surface were completely obscured while the amide bands of the collagen layer remained 
significant.  
In contrast to this, when scales were modified by the radical polymerization of the 
hydrophilic OEGA monomer, a significant preference for modification of the collagen 
layer was seen. The FTIR of the top and bottom surfaces (Figure 6.7b) show a significant 
increase in the C–H stretch at 2873 cm-1 in the collagen layer, but just a small C–H 
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stretch is seen in the spectrum of the biomineral layer. The C=O stretching band at 1725 
cm-1 and the C-O stretching band at 1103 cm-1 were also strong in the collagen surface’s 
spectrum and negligible in the biomineral surface’s spectrum.  
Scales modified by the radical polymerization of the hydrophobic monomers, MMA or 
MA, yielded spectra that showed no obvious difference when compared to FS and FS-W. 
This could be because the hydrophobic MMA and MA monomers failed to effectively 
wet or penetrate into the collagen, while the more hydrophilic OEGA was able to form a 
membrane on the surface of the collagen layer. However, if the more hydrophobic 
monomers penetrated into the fish scale without significantly altering the FT-IR spectra 
we should still see changes in other properties.  
It should be emphasized though that the scales were only soaked in monomer at room 
temperature, and then removed for heating to favor surface modification over extensive 
modification of the hierarchical scale structure. More extensive modification would be 
expected if the scales were immersed in heated monomer, and/or a solvent was added, but 
this research sought to maintain the hierarchical structure of the scale, so solvents and 
high heat were both avoided here. These results show that modification by metal 
alkoxides and by hydrophilic monomers is a facile modification while the FTIR suggest 
that significant modification of either scale surface is modest. 
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102B6.3.3.2 Changes in Equilibrium Moisture Content (EMC) of polymer-modified fish 
scale 
202BTable 6.3 EMC of polymer-modified samples at 48 hours (80% relative humidity) 
Polymer-Modified Fish Scale 
(w.t.%) 
FS-SiO2 10.5±0.2 
FS-PMMA 11.2±0.2 
FS-POEGA 9.5±0.3 
FS-PMA 10.4±0.2 
 
176BFigure 6.8 EMC of Polymer-modified fish scales 
The EMC of polymer-modified samples data had been shown in Table 6.3 and Figure 6.8. 
Because we expected one application for an organic polymer modified fish scales might 
be as an additive in some packaging materials, we looked at the EMC of the polymer-
modified scales. In comparison to the EMC of the FS-W scales (11.8±0.3 w.t.%) all the 
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polymer-modified fish scales gave some reduction in EMC, but the greatest reduction 
came from the most hydrophilic modification, FS-POEGA at 9.5±0.3%. The most 
hydrophobic organic polymer modification (FS-PMMA) gave the highest EMC at 
11.2±0.2 w.t%. The fact that the scales modified with hydrophobic monomers (FS-
PMMA and FS-PMA) did not give significant reductions in EMC could be because these 
monomers failed to significantly alter the surfaces of the scales, as suggested by the FTIR 
spectra. But the FTIR of FS-POEGA and FS-SiO2 proved significant modification of the 
scales, and they also showed little significant change in the EMC compared to FS-W 
scales. This suggests that both the collagen and biomineral layer would need to be 
modified to significantly alter the EMC. But, it does still not explain exactly what change 
occurred during the ultrasonic treatment that resulted in such a significant rise in the 
EMC. 
80B6.3.4 Nanomechanical properties 
Another likely application for fish scales is as composite reinforcement.  We tested the 
effects of our modifications on the nanomechanical properties of the modified, but 
otherwise intact, scales. We tested the surface of the biomineral layer, and tested the 
collagen layer in cross-section, from the middle and closer to the edge of the collagen 
layer. 
103B6.3.4.1 Biomineral surfaces  
Table 6.4 lists the DMT modulus measured for the biomineral surface of all the scales 
studied here. The DMT modulus, was obtained using the peak-force tapping mode in the 
AFM, as described elsewhere.25 The modulus of the as-received FS was only 3.963 GPa, 
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and rose slightly to 4.219 GPa for the FS-W. The slight rise in the modulus of FS-W 
supports the removal of some residual soft layer from the surface of FS.   
The modulus of the FS-H scales should be dominated by the modulus of the collagen 
layer if the biomineral layer were removed, since the acid soak is intended to degrade the 
biomineral layer. Soaking in base was intended to degrade the collagen layer, leaving the 
modulus of the scale to be dominated by the biomineral layer since. However, the 
modulus of FS-H and FS-OH scales is quite low, at 1.767 GPa and 2.162 GPa 
respectively, compared to 3.963 GPa for FS. The FTIR spectra of the FS-H and FS-OH 
scales showed bands from collagen and the biomineral components indicating that acid 
and base did not degrade either layer completely but damaged both layers sufficiently to 
compromise the mechanical properties of the scales.   
Treatment with acid destroys the hydroxyapatite directly, so loss of mechanical properties 
from the biomineral surface is expected. The loss of properties in the FS-OH scales may 
be due to the fact that hydroxyapatite is not the only component of the biomineral layer. 
There are other organic components that give order to the inorganic domains, so the base 
solution could have degraded both the collagen and the organic components in the 
biomineral layer, damaging the inherent structure leading to loss of properties. Further 
treatment of the biomineral layer with base would ultimately lead to removal of all the 
organic components from this layer, only leaving hydroxyapatite powder.  
 The most interesting result from the non-polymer modifications of scales is from the FS-
C. The modulus of the FS-C scales was 4.687 GPa, which is somewhat greater than that 
of the FS or FS-W scales. The FTIR of the oxidized biomineral surface showed decreases 
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in peaks at 1540 and 1633 cm–1 (protein) relative to the peak at 1012 cm–1 (PO43-). And, 
compared to the FS spectra changes in the relative ratio of the peak areas occurred in the 
IR spectrum of both sides of the scale, so the rise in modulus might be due to some 
changes in the proteins in the biomineral layer but the exact changes are not clear. 
The most substantial change that resulted from one of the supplemental polymerization 
modifications came from the in situ hydrothermal conversion of TEOS to SiO2 
nanoparticles. This modification was expected to increase the modulus of the scales and 
to reduce the moisture uptake. Figure 6.9 shows optical and AFM images of the 
biomineral surface of FS, FS-SiO2-C and FS-SiO2.  As seen from Table 6.4, the modulus 
of the as-received FS was only 3.963 GPa, but more than doubled to 8.572 GPa for FS-
SiO2-C, and rose to 22.839 GPa for FS-SiO2. The structure of the biomineral surface was 
also visibly changed from FS (Figure 6.9a), where ridge features were clearly visible. 
With a 30 min immersion in acidified TEOS followed by thermal treatment the 
depressions begin to fill in with SiO2 nanoparticles (Figure 6.9b), and the ridge features 
start to become obscured. After a 60 min immersion followed by the same thermal 
treatment the surface is nearly featureless (Figure 6.9c). 
203BTable 6.4 Modulus (GPa) of the biomineral surface of fish scales 
Modified Fish Scale  Polymer-Modified Fish Scale  
FS 3.963 FS-SiO2-C 8.572  
FS-W 4.219 FS-SiO2 22.839 
FS-H 1.767 FS-PMMA 4.904 
FS-OH 2.162 FS-POEGA 1.201 
FS-C 4.687 FS-PMA 3.821 
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All the organic polymer-modified fish scales gave small changes in modulus, but it is not 
obvious how much the biomineral surface of the scales was modified. The hydrophobic 
polymers PMMA and PMA gave small or negligible effects on the modulus (4.904 and 
3.821 GPa respectively) compared to unmodified FS. Because hydrophobic materials do 
not readily wet hydrophilic surfaces these hydrophobic monomers and polymers may 
simply have failed to modify the scales to a significant extent. However, the hydrophilic 
OEGA monomer gave POEGA-modified scales with significantly reduced modulus 
(1.201 GPa). This indicates that the hydrophilic OEGA monomer altered the surface 
more effectively than the hydrophobic monomers, leading to a soft POEGA membrane 
on the surface. Modification of the biomineral surface appears to be by adsorption to the 
surface, rather than grafting from the surface. 
 
177BFigure 6.9 Optical and AFM images showing changes in surface features of (a) FS, (b) 
FS-SIO2-C and (c) FS-SiO2. 
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104B6.3.4.2 Cross section of the samples 
To determine if the monomer reactants penetrated into the collagen layer we tested the 
mechanical properties of scale cross-sections. The modulus of the collagen was measured 
near the biomineral interface (labeled as “top side”) and more deeply into the collagen 
layer (labeled as “back side”) as illustrated in Figure 6.10A.  
 
178BFigure 6.10 Cross section AFM test (6μm Х 6μm) 
The modulus of the back and top edges of the FS control was measured at 2.21 GPa and 
5.24 GPa respectively (Table 6.5). In the AFM images for these sections (Figure 6.10B 
left and right respectively) the collagen rods are clearly visible. The higher modulus from 
the top side collagen rods is attributed to the reinforcing effect of the intact biomineral 
layer.  
130 
When the scales were modified by TEOS, the AFM image (Figure 6.10C, top left) clearly 
shows the presence of SiO2 nanoparticles. In the topside image the nanoparticles 
completely obscure the appearance of the bundles of collagen rods, while in the backside 
images the bundles are still visible. The size of individual SiO2 nanoparticles is not clear, 
but most of the aggregates appear to be ~ 100 nm. The presence of these nanoparticles 
within the collagen layer verifies confirms the FTIR results that showed SiO2 in both the 
biomineral and collagen layers. The reinforcing effect of the SiO2 on the collagen phase 
is confirmed by the significant rise in modulus both near the biomineral surface and deep 
within the collagen layer too (12.67 GPa and 10.21 GPa respectively). 
204BTable 6.5 Modulus of cross-sectional layers of scales (GPa) 
Modulus FS-W FS-SiO2 FS-PMMA FS-PMA FS-POEGA 
Near Top Edge 5.24 12.67 4.30 3.31 6.89 
Near Back Edge 2.21 10.21 3.64 2.23 2.08 
 
When the scales were modified with hydrophobic monomers, MMA and MA, the 
modulus near the biomineral layer of FS-PMMA and FS-PMA was reduced, compared to 
FS-W. Interestingly, the modulus of FS-PMMA within the collagen layer was increased 
relative to FS-W, while that of FS-PMA was unaffected. These effects may be due to 
some small degree of modification by polymers with relatively high (PMMA) and low 
(PMA) Tgs. FTIR did not show evidence that either surface of the scales was modified by 
MMA or MA, but the change in the modulus suggests there might have been some degree 
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of modification. However, as these changes are relatively small and the reasons for them 
need to be better understood.  
When the scales were modified with OEGA there was a very small change in the 
modulus of the collagen layer but the modulus near the biomineral surface rose was 6.89 
GPa compared to the FS-W control at 5.24 GPa. The modulus near the bottom edge was 
slightly smaller than the control (2.08 GPa compared to 2.21 GPa). In this case though 
the FTIR was able to confirm chemical modification by the hydrophilic OEGA monomer. 
The softening of the collagen layer could be attributed to the ability of the ethylene glycol 
units to interact with the collagen protein and to hydrogen bond with it, but the higher 
modulus near the biomineral layer is less clear. Also, the bundles of collagen rods are less 
distinct than in the other images, suggesting the possibility that the OEGA disrupted the 
collagen arrays. However, all these modifications need to be studied further. 
33B6.4 Conclusions 
This work sought to explore the possibility of expanding the use of fish scales as a waste 
resource, from beyond that of simply harvesting their major components, and to see if 
beneficial properties could be obtained by using their inherent hierarchical design. 
Because this hierarchical structure uses alternating layers of collagen rods and an upper 
biomineral layer, scales possess excellent toughness and the design has some similarities 
to structures that have useful gas barrier properties. Fish scale structures may find 
potential applications for use in biodegradable composites, packaging, or gas barrier 
materials. Because all these potential applications will require good interfacial adhesion 
between the scale and the matrix this research focused on investigating how different 
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chemical modifications affected chemical functionality, moisture uptake, and 
nanomehcnaical properties. This is the first research to investigate chemical 
modifications of fish scales and their effects on functionality and nanomechanical 
properties of modified fish scales. We also investigated the individual effects of 
modification on the biomineral and the collagen layer of the scale. The key positive 
findings are that while modifications can be targeted to the biomineral or the collagen 
layer, all the modifications had some effect on both layers. Gentle acid treatment partially 
removes the biomineral layer while gentle base treatment partially removes the collagen 
layer, but both treatments affected both layers. The less selective modification was base 
treatment, presumably because organic domains within the biomineral layer were also 
hydrolyzed by this treatment. A partial degradation of the collagen layer increased the 
nanomechanical modulus of the scale, presumably at the expense of the toughness, which 
is an attribute of the tiered collagen rods. Chemical modifications made by soaking in 
hydrophilic or hydrophobic monomers, followed by polymerizing the monomer in situ, 
showed that hydrophobic monomers were less successful in modifying the scales than 
hydrophilic ones, based on little change in FTIR spectra, but significant changes in the 
nanomechanical properties at both surfaces showed that modification occurred. Changes 
at the biomineral surface are attributed to adsorbed polymer that is not removed by 
washing with water. Both hydrophobic and hydrophilic modifications resulted in 
increasing the EMC of the scales compared to unmodified scales, which suggests that 
unidentified structural changes occurring to the scales that permitted the additional 
moisture uptake. Modification of the scales by TEOS resulted in substantial increases in 
the modulus of both the biomineral and collagen layers, arising from the formation of 
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SiO2 nanoparticles. The overall significance of these results is that the two different scale 
surfaces can be preferentially modified even if not independently modified, and that the 
wide range of modifications may allow these scales to be used in other applications while 
enhancing selected properties and altering interfaces for interaction with desired matrices. 
This work showed that a wide range of modifications is possible to adjust the modulus 
and polarity of a scale interface, though one issue that will need to be addressed before 
scales can find wider use is designing efficient scale size reduction tools, particularly one 
based on cutting rather than grinding, to enhance blending of scales into polymer 
matrices. 
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39BAppendix A: Supporting information for Chapter 3 
The NMR data: 
We synthesized three chain transfer agents (CTA): TC1, TC2 and TDT using methods 
reported in the literature. Figure S1 shows the 1H NMR(a) spectrum and 13C NMR (b) 
spectrum for S, S’-bis(?,??-dimethylacetic acid) trithiocarbonate (BDAT / TC1) 
synthesized following the procedures of J. T. Lai, D. Filla, R. Shea. Macromolecules 
2002, 35, 6754-6756). Figure S2 shows the 1H NMR spectrum for Dibenzyl 
trithiocarbonate (TC2) synthesized using the procedures of N. Aoyagi, T. Endo. J Poly 
Sci Poly Chem 2009, 47, 3702-3709).  Figure S3 shows the 1H NMR spectrum of 1,3,5-
Benzenetricarbodithioic acid (TDT), synthesized following the procedures of A. Dureault, 
D. Taton, M. Destarac, F. Leising, Y. Gnanou. Macromolecules 2004, 37, 5513- 5519. 
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179BFigure A1 TC1 (a) 1H NMR spectrum and (b) 13C NMR spectrum 
 
Dibenzyl trithiocarbonate (TC2) 
 
180BFigure A2 TC2 1H NMR spectrum 
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1,3,5-Benzenetricarbodithioic acid (TDT) 
 
181BFigure A3 TDT 1H NMR spectrum 
 
The Gel Permeation Chromatography (GPC) data 
205BTable A1 Molecular weights and PDI of PEG standard polymers. 
Standard Mn, Da Mw, Da PDI 
1 895 1020 1.14 
2 10600 12200 1.15 
3 22100 25800 1.17 
4 31700 41300 1.30 
5 81900 94600 1.16 
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182BFigure A4 GPC spectra of PEG standard polymers. (RI Intensity vs PEG Retention Time 
(min). 
 
206BTable A2 Molecular weight and Polydispersity by GPC  
Specimen Mw PDI 
DT1/ S-D50O50-C1 44000 3.49 
DT1/ S-O50D50-C1 27900 2.46 
DT2/S-D50O50-C2 38800 3.08 
DT2/ S-O50D50-C2 29200 2.56 
DT3/S-D50O50-C3 30900 4.71 
DT3/ S-O50D50-C3 21300 2.47 
161 
TC1/ C-O25D50O25-C 37800 4.42 
TC1/ C-D25O50D25-C 22700 2.67 
TC2/ Ph-O25D50O25-Ph 30800 3.42 
TC2/ Ph-D25O50D25-Ph 33800 3.72 
TDT/ S-(D50O50)3-C6 77100 5.69 
TDT/ S-(O50D50)3-C6 81400 5.86 
 
 
183BFigure A5 GPC of Specimen TC1/C-D25O50D25-C 
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40BAppendix B: Derjaguin-Muller-Toropov (DMT) modulus 
background (Chapter 6) 
The Derjaguin-Muller-Toporov (DMT) model of modulus is based on Hertzian model. It 
is suitable for describing stiff contacts with low adhesion forces and small tip radii,1 
therefore it is widely used in AFM nanomechanical measurements to calculate the 
modulus of the sample. To understand the DMT model, we must consider the Hertzian 
model first. 
The Hertzian model2 begins with the following assumptions: 
1) The strains are small and within the elastic limit 
2) The surfaces are continuous and non-conforming (implying that the area of 
contact is much smaller than the characteristic dimensions of the contacting 
bodies). 
3) Each body can be considered an elastic half-space. 
4) The surface is frictionless. 
Based on these assumptions, the DMT model1, 3 then takes into consideration the 
attractive interactions outside the area of contact (adhesion).  
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184BFigure B1 The basic DMT model 
Figure B1 illustrates how a probe tip would contact and indent a surface (relative areas 
not to scale). ϒ1 and ϒ2 are the surface energy of each of those surfaces that will be in 
contact but before they actually do contact, while ϒ12 is the surface energy of the contact 
area after contacting. R is the radius of the sphere and a is the radius of contract area. 
When an AFM probe tip contacts a surface it applies a force, F, which is the force 
(positive in compression). A specific probe tip will have known quantities, including a 
given spring constant, so that the work needed to indent a polymer surface can be 
calculated as long as the probe tip is first calibrated to that surface, which allows 
determining ϒ2 and ϒ12. Therefore, when the tip is withdrawn from the surface a Δϒ is 
measured, which is defined the work of adhesion:  Δϒ = ϒ1 + ϒ2 - ϒ12. This value is 
extracted from Equation B1 and can also be seen in Figure B2 as the difference in energy 
needed to withdraw the probe from its deepest point of indentation back to the surface of 
the material being indented. Furthermore, because the tip is calibrated the stiffness, or 
modulus of a material being indented, E can also be extracted from Equation B1, and is 
taken as the slope of the linear part of the curve from when the probe tip moves forward 
to indent the surface of the material being tested.  
164 
?? ? ???? ?? ? ?????? ??? ???? ?
??
?? ?? ? ?????? Equation B1 
 
185BFigure B2 DMT modulus of fish scale tested by AFM (Adapted from Beilstein J. 
Nanotechnol. 2013, 4, 611–624.) 
In this work, the DMT modulus of fish scale was test by AFM using a peak force tapping 
mode. The calibrated probe (10~15 nm) and instrument software (Nanoscope Analysis 
v1.4) generate nanomechnical maps of sample surfaces by generating a small indentation 
on the sample surface and collecting a force-separation curve4 as illustrated in Figure B2. 
Using this force separation curve the adhesion and DMT modulus are calculated by 
fitting to the DMT model5 and using Equation B2: 
? ? ?? ?????? ? ????  Equation B2 
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Where F is the force, R is the tip radius, d is the separation, Fadh is the adhesion force, 
and E* is the reduced elastic modulus. The elastic modulus of the probe (Etip) is much 
greater than sample modulus Es and the Poisson’s ratio of the sample is known as vs, so 
the young’s modulus for the sample (Es) can be calculated5 (Equation B3):  
 ?? ? ???????? ?
???????
???? ?
?? ?? ?? ??? ?
?????
?? ?
?????
?? ?
?????
??   Equation B3 
The deflection sensitivity of the cantilever spring constant was measured by indenting a 
known material: a hard sapphire surface (56.67 nm/V). Then the cantilever spring 
constant adjust by using thermal tuning method (K = 38.9 N/m). The quantitative 
nanomechanical maps were generated by force-separation curves. All the modulus data of 
fish scale samples were the average data from an area (~2 μm × 2 μm) in nanomechanical 
maps. 
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42BAppendix D: Permission License Number for Figures in 
Chapter 2 
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